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Christopher John Pace
­
Under the guidance of Jianmin Gao
­
ABSTRACT
The oligomerization of membrane proteins has been shown to play a critical role
in a myriad of cellular processes, some of which include signal propagation, cell­to­cell
communication, and a cell’s ability to interact with its surroundings. Diseases that are
associated with disruption of protein­protein interactions in the membrane include
cystic fibrosis, certain cancers, and bone growth disorders. Although significant progress
has been made in our mechanistic understanding of protein­protein interactions in
membranes, it remains difficult to predict the oligomerization state of transmembrane
domains and explain the physiological consequences of a point mutation within a
membrane embedded protein. The development of novel classes of chemical tools will
allow us to better understand the energetics of transmembrane domain association at the
molecular level.
Herein, we demonstrate that fluorinated aromatic amino acids offer intriguing
potential as chemical mediators of transmembrane protein association. We have
systematically examined the effects of fluorination on the physical properties of aromatic
systems in the context of a soluble protein model system. Our results illustrate the ability
of fluorinated aromatic amino acids to simultaneously stabilize protein structure and
facilitate highly specific protein self­assembly. An improved understanding of the
fundamental energetics of aromatic interactions should allow for their more efficient
incorporation into designed inhibitors of transmembrane protein association.
            
            
            
          
            
            
               
        
           
 
            
             
              
            
 
 
 
 
 
 
 
 
 
 
 
 
In addition to chemical tools, the development of simple methods for directly
­
monitoring transmembrane domain association in vitro and in vivo is necessary to
advance our understanding of these interactions. Towards this goal, we have established
FlAsH­tetracysteine display as an effective approach to quantifying the association
propensities of transmembrane α­helices (TMHs) in vitro. Our assay is compatible with
two of the most commonly utilized model membrane systems, detergent micelles and
vesicles. The high spatial resolution of FlAsH binding (< 10 Å) allows for the
differentiation of parallel and antiparallel oligomerization events. Importantly,
preliminary studies suggest the assay’s ability to detect inhibition from exogenous
TMHs.
Encouraged by our understanding of aromatic interactions and the success of our
assay, we are beginning to incorporate fluorinated aromatics in the model TMHs and
monitoring their ability to associate. The ultimate goal is to modulate the association of
endogenous TMHs such as ErbB2. Research in this direction is ongoing.
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1.1  Membrane proteins in biology
Membrane proteins, one of the major protein classes, can be loosely defined as
being inserted into, attached to, and/or associated with the cell membrane. These
proteins perform essential cellular functions such as the transport of molecules and ions
into and out of the cell, communication between the intracellular and extracellular
environments, and mediate cell mobility and adhesion. This biological importance is
reflected in the number of drugs in that target membrane proteins (~50%) relative to
their distribution in the proteome (20­30%).1 Therefore, a clear understanding of
membrane protein structure and function is of the utmost importance to chemistry,
biology, and drug discovery. Due to the practical difficulties in obtaining structural data
for membrane­associated proteins, it is particularly critical to understand how their
function is regulated to expedite the development of novel therapeutic agents. One of the
most commonly observed strategies utilized by proteins to control function is oligomer
formation. The importance of membrane protein association in protein function, and the
physiological consequences of abnormal protein­protein interactions in the membrane,
will be discussed below.
1.2  Membrane protein function – protein­protein association
The oligomerization of membrane proteins has been shown to play a critical role
in a myriad of cellular processes, some of which include signal propagation, cell­to­cell
communication, and a cell’s ability to interact with its surrounding environment. Not
surprisingly, a number of serious diseases are associated with loss or gain of membrane
protein association. For example, human genetic diseases such as cystic fibrosis and
hypomagnesemia, as well as certain cancers and neurodegenerative diseases, are known
to be associated with point mutations in the transmembrane domains of membrane­
embedded proteins (Table 1­1).2­11 
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Table 1­1. Examples of pathogenic transmembrane domain mutations
­
Protein Point Mutation Disease
FGFR1
­­
FGFR2
­­
FGFR3
­­
­­
­­
FGFR4
ErbB2
CFTR
­­
Na+,K+­ATPase
Y372C
C379R
S372C
Y375C
G380R
V381E
G382D
A391E
G288R
I654V
V232D
R347E
G41R
Osteoglophonic dysplasia
Osteoglophonic dysplasia
Beare­Stevenson cutis gyrate syndrome
Beare­Stevenson cutis gyrate syndrome
Achondroplasia
Hypochondroplasia
Multiple myeloma
Bladder cancer
Tumor progression
Breast Cancer
Cystic fibrosis
Cystic fibrosis
Dominant renal hypomagnesemia
In 2004, an analysis of the Human Genome Mutation Database by Deber and co­
workers found 80 mutations in transmembrane domains that are associated with human
disease.12 The physiological significance of membrane protein oligomerization to normal
cell function is best exemplified by the family of ErbB growth factor (EGF) receptors.
This family of membrane­spanning proteins will be discussed in greater detail below.
1.2.1  The biological significance of membrane protein association
The oligomerization behavior of the EGF receptors, a family of receptor tyrosine
kinases (RTKs), has been investigated and characterized extensively over the last two
decades. The RTKs are single­pass membrane proteins with an extracellular ligand
binding domain and an intracellular kinase domain. The EGF subfamily is made up of 4
proteins: ErbB1, ErbB2, ErbB3, and ErbB3, all of which are involved in the regulation of
cell growth and differentiation at all stages of life. They propagate biochemical signals
via dimerization, which results in trans­phosphorylation and subsequent activation of
downstream signaling pathways. There are two generally accepted mechanisms for EGF
3
­
association and signal propagation (Figure 1­1).13 While the extracellular ligand is 
thought to mediate the equilibrium between closed and open states for the extracellular 
domain, there is still controversy surrounding the ability of other EGFs besides ErbB2 to 
dimerize through transmembrane domain interactions. 
 
 
Figure 1­1. The widely accepted models of RTK­mediated signaling. All RTK such as the 
EGFs exist in equilibrium between monomeric, dimeric, and ligand­bound dimeric forms. In 
Model 1, the active dimer conformation 3A is stabilized by ligand binding, which shifts the 
equilibrium further towards the active conformation 4A. In Model 2, ligand binding is 
required to alter the dimer conformation from inactive 3B to active 4B. Both models allow for 
inherent association propensities between transmembrane domains to modulate the activity 
of RTKs (IA, IIA, IB, and IIB). This image has been adapted from Reference 13. 
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Many of the efforts at understanding the mode of EGFR association were
motivated primarily by the discovery that a single Val664Glu mutation in the
transmembrane domain of ErbB2 induces uncontrollable dimerization and constitutively
activates the receptor. This increased dimerization results in the production of Neu, a
known oncogene.14, 15 Point mutations in the EGFR receptors, particularly ErbB2, have
long been associated with an increased risk of breast cancer and glioblastomas.15 Shortly
thereafter, it was discovered that several transmembrane domains indeed display
association behavior even in the absence of their extracellular and intracellular
domains.16 Notably, an NMR structure of the ErbB2 transmembrane domain dimer has
been obtained, which provides insight into important molecular contacts established
upon association.17 Our improved understanding of EGFR function has led to the
approval of the monoclonal antibody Trastuzumab for the treatment of ErbB2­positive
metastatic cancers within the past several years, an important validation of the
therapeutic potential of mediating membrane protein association.18 Although significant
progress has been made in our mechanistic understanding of protein­protein
interactions in membranes,19­24 it remains difficult to predict the oligomerization state of
transmembrane domains and explain the physiological consequences of a point mutation
within a membrane embedded protein. The current understanding of the energetics of
membrane protein oligomerization have been summarized below, with a particular
emphasis on transmembrane α­helical (TMH) domains, since the α­helix is the most
commonly observed secondary structure of self­associating transmembrane domains.
1.2.2  The thermodynamics of membrane protein association
In order to rationalize the dramatic effects of point mutations on membrane
protein association propensity, one must consider the unique local environment of the
lipid membrane. Because the solvent effects of water are absent, factors important for
association should differ greatly from those that govern soluble protein­protein
5
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interactions. For example, while the association of soluble proteins is primarily driven by
­
the hydrophobic effect, protein­protein interactions within the lipid bilayer cannot rely
on hydrophobicity as a driving force for association (Figure 1­2). Rather, the
association of membrane­spanning proteins is dictated predominantly by noncovalent
interactions such as sidechain hydrogen bonding and van der Waal’s packing.19, 20
Figure 1­2. The two­stage model for helical membrane protein association. Stage I: while
the insertion of individual protein domains into the lipid membrane is certainly dictated by
the hydrophobic effect, secondary structure formation of individual domains is driven chiefly
by main­chain hydrogen bonding, which should be even more energetically favorable in the
lipid bilayer. Stage II: protein association is driven principally by noncovalent interactions
between the sidechains of interacting helices. The maximum energetic potential of
noncovalent forces such as hydrogen bonding and van der Waal’s packing should be realized
in this environment. This figure has been adapted from Reference 19.
These electrostatic contacts should be at their highest strength in the low
dielectric environment of the membrane bilayer, having been sequestered from
competing water molecules. It has been elucidated that specific “interaction sequence
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motifs” exist that promote the association of transmembrane domains. As our
­
understanding of the energetics behind these interactions has improved, the
development of novel chemical tools that are able to further elucidate the importance of
these fundamental interactions is critical to the development of general therapeutic
approaches. Selected well­characterized sequence motifs and their potential significance
to biology and drug development are described below.
1.2.3  Role(s) of polar residues in membrane protein association
In addition to the maximization of van der Waal’s contacts, sidechain hydrogen
bonding has been proven both in vitro and in vivo to effectively drive transmembrane
domain association.25­28 As expected, these hydrogen bonds are formed between the
sidechains of polar amino acids. Residues possessing two hydrogen bonding motifs, such
as Asn (N), Gln (Q), Asp (D), and Glu (E), are more likely to promote association
compared with Ser (S) and Thr (T) because they are capable of forming more stable
hydrogen bonding networks.25­28 Not surprisingly, many of the pathogenic point
mutations associated with transmembrane domains involve the insertion or elimination
of a polar residue (Figure 1­1). Positively charged residues such as Arg (R) and Lys (K)
have also been implicated in dictating membrane protein association, both in native
proteins and pathogenic mutants.9, 12, 14, 19 Further studies need to be conducted in order
to better understand and manipulate membrane protein association via these polar
amino acids.
1.2.4  Role(s) of aromatic residues in membrane protein association
Interestingly, aromatic amino acids also appear to be critical to the proper
association and function of some membrane­spanning proteins. For example, oligomer
formation by amyloid polypeptides is thought to be facilitated by π–π contacts between
aromatic residues. A point mutation that eliminates an aromatic residue has been shown
to prevent amyloid fibril formation and supports the importance of aromatic contacts.29 
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Moreover, Kumar and co­workers have demonstrated the ability of aromatic residues to
­
facilitate orthogonal self­assembly in soluble coiled­coil peptides.30 Through use of the
genetic POSSYCAT system, Langosch and co­workers screened a library of sequences for
self­association propensity and found that Trp­enriched sequences readily associate with
high affinity.31 In agreement with these data, Shai and co­workers have reported on the
first known example of a natural transmembrane domain, the cholera toxin secretion
protein EpsM, that possesses a self­assembly motif made up of aromatic residues
(WXXW). Replacement of both Trp with Tyr does not significantly alter the association
propensity of EpsM, but when both are replaced with Ala, oligomerization is completely
disrupted (Figure 1­3).32 
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Figure 1­3. Aromatic residues dictate the association of the natural transmembrane domain
EpsM. (a) Primary sequences of EpsM variants; (b) Monitoring dimerization levels of EpsM
WT and select variants using the ToxR system. All expression levels and proper membrane
integration have been ensured (data not shown). Protein association is only eliminate upon
mutation of both Trp residues to the non­aromatic Ala. These images have been adapted
from Reference 32.
These results suggest a general role for aromatic interactions in mediating
membrane protein association, since the WXXW interaction motif is only dependent on
the aromatic nature of the sidechain and not its specific identity. Furthermore, aromatic
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residues may offer the ability to specifically recognize individual native transmembrane
­
domains while not interfering with other interaction motifs, such as hydrogen bonding
and van der Waal’s packing. Further investigation into these interactions at the
molecular level will require chemical tools for probing their energetic potential.
1.3 	 Conclusion – mediating membrane protein association and function
with fluorinated aromatic amino acids
Due to their involvement in countless cellular processes and pathways,
membrane proteins are essential for cell growth, proliferation, and survival. The
activities of many families of membrane­spanning proteins (i.e. EGFRs) are controlled
by protein­protein association. Alteration of these association propensities has been
implicated in a number of diseases and disorders (Table 1­1). Efforts towards
understanding transmembrane protein association have identified key sequence motifs,
which contain both polar and aromatic amino acids, that are important in driving
oligomerization.
Despite the incredible progress made over the last two decades, we still require a
better understanding of these fundamental interactions at the molecular level. Chemical
tools for probing these interactions will help immensely in understanding their
significance. Additionally, novel strategies of assessing membrane protein association in
vitro and in vivo must be developed. Herein, we propose to address these obstacles
through two approaches:
1)  The use of fluorinated aromatic amino acids as chemical tools for systematically
probing the energetics of aromatic­aromatic interactions in proteins (Chapter 2)
2)  The development of a fluorescence­based assay, using the biarsenical
chromophore FlAsH­EDT2 for assessing the potential of fluorinated aromatic
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amino acids as mediators of α­helical transmembrane peptide (TMH) association
­
(Chapter 3).
We have utilized a combination of organic chemistry, peptide chemistry, and
biophysical analysis in both studies. Our efforts towards achieving both of these goals
will be the focus of further discussions.
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Chapter 2
�
Fluorinated Aromatic Amino Acids as Tools for Exploring and
�
Exploiting Polar­π Interactions in Proteins
�
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2.1  Introduction
�
The overwhelming complexity of membrane protein structure and function
necessitates the continual and rapid development of novel chemical tools and techniques
for manipulating their behavior addressing challenges in biomedicine. Fluorine has
recently emerged as an increasingly attractive element for use in medicinal chemistry
and protein engineering.1­4 Notably, today a significant number of all pharmaceuticals
contain one or more fluorine atoms despite its virtual absence from nature (Figure 2­1).
Because of its biocompatibility, fluorination has also become a standard approach for
modifying the structure and/or function of proteins. The unique stereoelectronic
properties of fluorine are responsible for its wide range of applications in protein
chemistry, drug development, and biomaterials. These properties, which make fluorine
ideal as a chemical tool for examining transmembrane association, will be discussed in
greater detail below in the context of recent developments in the field.
2.1.1  Fluorine in medicinal chemistry & protein engineering
Fluorine’s unique set of stereoelectronic properties combined with its absence
from most biological systems have led to its wide use in drug development and
biomedicine. A recent estimate puts the number of pharmaceuticals currently on the
market that contain fluorine to be at 20%, among these commonly prescribed drugs such
as fluoxetine (Prozac ®) and atorvastatin (Lipitor ®) (Figure 2­1).4 Atorvastatin, in
particular, has been proven to possess superior affinity for its target, HMG­CoA
reductase, when fluorinated.5 In addition to pharmaceuticals, as many as 30% of all
agrochemicals contain fluorine.4 The most important properties of fluorine are its small
size, high electronegativity, low polarizability, and virtual nonexistence in nature. The
physical and chemical consequences of these properties will be discussed below.
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Ciprobay ® Januvia ® Adrucil ® 
(Fluorouracil) (Sitagliptin) (Ciprofloxacin) 
Antimetabolite Type II Diabetes Antimicrobial 
Lipitor ® Prozac ® 
(Fluoxetine) 
Flonase ® 
(Atorvastatin) (Fluticasone propionate) 
Corticosteroid Antidepressant Cholesterol 
Prevacid ® 
(Lansoprazole) 
Antacid 
Celebrex ® 
(Celecoxib) 
Arthritis 
Crestor ® 
(Rosuvastatin) 
Cholesterol 
Figure 2­1. Selected examples of pharmaceuticals that contain one or more fluorine atoms
(highlighted in red). Fluorine serves a variety of roles in drug design, such as improving drug
efficacy, modulating pharmacokinetics, and improving selectivity.
Perhaps the most exciting advantage of incorporating fluorine into both small
molecules and proteins lies in its low abundance in biology. Because it is rarely found in
nature, fluorine can serve as an effective bioorthogonal probe with negligible
background. Using 19F­NMR, Pielak and coworkers have demonstrated its ability to
spatially and temporally monitor proteins in living E. coli.6 The 19F nucleus is about as
sensitive (86%) as the 1H in NMR spectroscopy, and it has a broad range of chemical
shifts that are extremely sensitive to changes in its local environment. It is therefore not
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surprising that fluorination has been shown, both by our lab and others, to be an
­
effective probe of protein­membrane association.7, 8 
Besides its low natural abundance, fluorine’s widespread use can be traced to its
unique properties. First, fluorine is the smallest of all the elements except for hydrogen.
The van der Waals radius of fluorine (1.35 Å) and the C–F bond length (1.34 Å for an sp2 
carbon) are only slightly larger than those of hydrogen (van der Waal’s radius of 1.2 Å,
C–H bond length of 1.09 Å)).9 Consequentially, fluorine represents one of the most
sterically conservative replacements for hydrogen in most small molecule and protein
systems. In addition to its tolerance in small molecules, fluorine substitution has been
shown to be well tolerated by a variety of proteins without introducing much steric
perturbation or structural rearrangement to the parent structure.10, 11 
Second, fluorination often increases the hydrophobicity of the altered molecule.12 
This phenomenon is primarily a consequence of fluorine’s small size and high
electronegativity, which results in it possessing one of the lowest polarizabilities of any
element.13 Enhanced hydrophobicity can be utilized to increase the binding affinity of the
fluorinated small molecule to its cellular target. Additionally, fluorination has been used
extensively to stabilize protein structure via this enhanced hydrophobicity.10 This point
will be discussed in greater detail below.
Finally, fluorine is easily incorporated into both small molecules and proteins.
Numerous commercially available fluorinating agents and methodologies have been
developed for introducing fluorine into small molecules and proteins chemically.4 In
particular, expressed protein ligation and Amber codon suppression technology have
allowed for the incorporation of fluorinated amino acids into proteins of all sizes.14­19
In addition to the widespread use in medicinal chemistry, the aforementioned
properties of fluorine also prove advantageous for the modification of protein structure
and function. In the following sections I will review recent investigations and
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applications of fluorinated amino acids in protein engineering. The proteinogenic amino
acids can be broadly classified as possessing either aliphatic or aromatic sidechains. The
effects of fluorination on each class and subsequent applications will be discussed in
greater detail below.
2.1.2 	 Fluorinated aliphatic amino acids – properties and applications in
protein engineering
Over the past few decades the majority of work involving fluorination as a protein
engineering strategy has largely focused on the use of fluorinated aliphatic amino acids.
Due to their enhanced hydrophobicity and low polarizability, these unnatural,
fluorocarbon­based residues have been utilized primarily to stabilize protein structure
and to afford self­sorting proteins. Recent applications of these amino acids will be
discussed in greater detail below.
A notable increase in hydrophobicity is a well­known consequence of the
fluorination of aliphatic moieties.12 A commonly employed method for comparing
relative hydrophobicities is by LogP, where P is the partition coefficient. Here, the
partition coefficient is defined as [Molecule X]Octanol / [Molecule X]Water at equilibrium. A
larger LogP value therefore corresponds to a more hydrophobic molecule. For example, a
leucine (Leu) to hexafluoroleucine (hfLeu) mutation results in an increase in the
sidechain LogP from 2.50 to 3.88. A similar trend is also observed with valine (Val) and
hexafluorovaline (hfVal), with calculated sidechain LogP values of 2.08 and 3.29,
respectively. Because of the critical role the hydrophobic effect plays in protein folding,
the insertion of these residues into proteins generally has a stabilizing effect. For
example, Marsh and coworkers have incorporated varying amounts of hfLeu residues
into a protein that forms tetrahelical bundles (Figure 2­2a).20, 21 The stability of the
peptide bundle increases as a function of the number of hfLeu mutations. Through
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thermodynamic analysis it was determined that each Leu to hfLeu mutation contributes
­
approximately –0.3 kcal mol–1 to the stability of the helical bundle.
Figure 2­2. Incorporation of fluorinated aliphatic amino acids elicits a stabilizing effect on
protein structure and is well tolerated by the native protein fold. (a) Introduction of
hexafluoroleucine (hfLeu) into a 4­helix bundle protein stabilizes the folded structure as a
function of the number of hfLeu mutations (0, 2, 4, or 6 mutations). Each hfLeu mutation
contributes –0.3 kcal mol–1. Fluorinated residues are shown in green. These images have
been reproduced from Reference 20; (b) Structural evidence for the tolerance of fluorine in
the hydrophobic core of a helical bundle protein. This cross­section illustrates that
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fluorination, despite a slight increase in size, still maintains the tight packing of the side
chains. Fluorine atoms are colored purple. These images have been reproduced from
Reference 11.
More recently, Marsh and coworkers have confirmed through crystallographic
studies that the increased steric bulk of these hfLeu residues is well tolerated by the
protein structure, presumably because the overall shape of the sidechain is maintained to
allow for optimal packing efficiency despite the small size increase (Figure 2­2b).11 The
ability of proteins to tolerate extensive fluorination without sacrificing native function
expands the potential scope of these chemical tools.
Much effort has also centered on using fluorinated aliphatic amino acids to
generate Teflon­like proteins that readily self­associate.21­24 This line of research was
initially inspired by the known phase separating behavior of fluorocarbons from both
aqueous and hydrocarbon solvents. This phenomenon has been termed “the fluorous
effect” and had previously been utilized extensively for product separation in organic
synthesis. Similarly, the insertion of fluorinated aliphatic residues at a protein­protein
interface should allow for self­sorting from both hydrophilic and lipophilic moieties.
Indeed, by fluorinating all the core residues of model coiled­coil proteins, Kumar and
coworkers demonstrated this self­sorting behavior when fluorinated and nonfluorinated
peptides were mixed in aqueous media (Figure 2­3a).23, 25, 26 Random dimer formation
should result in a significant population of heterodimers, but only homodimers were
observed upon mixing of the hydrocarbon monomers with their fluorinated analogues.
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Figure 2­3. Fluorinated aliphatic amino acids afford self­sorting proteins. (a) Disulfide
exchange experiment demonstrates the thermodynamic self­sorting behavior of soluble
coiled­coils containing Leu (Hb. grey) and hfLeu (Fb, green) residues. Peptides self­associate
to form homodimers from both preformed heterodimer (via redox exchange) and monomer
(via oxidation). This image has been reproduced from Reference 26; (b) Fluorinated
membrane­embedded helices self­associate once inserted, while their nonfluorinated
counterparts remain monomeric in the lipid bilayer. The oligomeric states of these
transmembrane α­helical peptides have been assessed via analytical ultracentrifugation
(AUC). This image has been reproduced from Reference 27.
Moreover, Kumar and coworkers have shown that “the fluorous effect” provides
protein engineers with a bioorthogonal mechanism for dictating the association of
membrane proteins within the lipid bilayer. A de novo designed transmembrane α­
helical peptide, which exists as a monomer in the lipid membrane, readily forms dimers
when hfLeu residues are incorporated (Figure 2­3b).27 As previously discussed, it is
well known that Nature accomplishes protein association in the lipid bilayer via
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sidechain hydrogen bonding and van der Waal’s packing.28­30 Fluorinated aliphatics are
therefore advantageous as orthogonal self­sorting motifs because they will not perturb
the association of the surrounding native proteins.
2.1.3  Fluorinated aromatic amino acids – physical properties
While the behavior of fluorinated aliphatic amino acids is largely dominated by
“the fluorous effect”, this phenomenon does not apply to fluorinated aromatics. For
example, unlike its perfluorinated aliphatic counterparts, the solubility of
hexafluorobenzene in hexanes is similar to that of benzene. Moreover, the mixing of
benzene and hexafluorobenzene is an enthalpically favorable process.31 Examination of
physical properties as well as structural studies support this observation. The melting
temperature of a 1:1 mixture of benzene and hexafluorobenzene is significantly higher
(23.1 °C) than those of the individual components (5.4 °C for benzene and 5.0 °C for
hexafluorobenzene).32 Furthermore, the cocrystal structure of the 1:1 mixture reveals an
alternating arrangement of benzene and hexafluorobenzene in a face­face stacking
geometry (Figure 2­4c).33 The distinct behavior of fluorinated aromatics compared with
fluorinated aliphatics can be attributed primarily to the effect of fluorination on the
electronics of aromatic rings.34, 35 
23
­
 Figure 2­4.  Effects of fluorination on the physical properties of an aromatic ring. (a) 
Structures and electrostatic potential (ESP) maps of benzene, 1,3,5­trifluorobenzene, and 
hexafluorobenzene, with relevant physical parameters shown in the table below the ESP 
maps; (b) An energetic analysis of the packing modes of benzene and hexafluorobenzene 
shows that edge­face (T­shaped) and offset­stacked are energetically favorable for the 
benzene dimer, while face­face stacked is favorable for the benzene­hexafluorobenzene 
dimer.36 These preferred packing modes agree with the calculated ESP maps; (c) Face­face 
stacking of benzene and hexafluorobenzene revealed by the cocrystal structure. This image 
has been reproduced from Reference 31. 
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While aliphatic molecules such as n­hexane display a relatively even distribution
of electron density, aromatic structures such as benzene exhibit an inherently uneven
electron distribution despite possessing no net dipole moment. This type of electron
distribution is referred to as a quadrupole (Figure 2­4a). A quadrupole allows aromatic
moieties to engage in a wide range of electrostatic interactions: with a charge
(exemplified by cation–π interactions), a partial charge, a dipole, or another quadrupole.
Such polar–π interactions explain why benzene molecules prefer to pack in the edge­face
(T­shaped) or offset­stacked geometries in crystal structures (Figure 2­4b).
Fluorination of an aromatic moiety, however, effectively reverses this electron
distribution, as fluorine pulls electron density away from the π cloud and toward the
edge of the molecule due to its strong inductive effect (Figure 2­4a). For example, the
10–40 m–2calculated quadrupole moment of benzene is –29.0 x C , while that of
31, 37 hexafluorobenzene is +31.7 x 10–40 C m–2. The incredible power of fluorination is
exemplified by the aforementioned benzene­hexafluorobenzene crystal structure:
fluorination alters the preferred stacking geometry and allows for complementary face­
face stacking due to the reversed quadrupole of hexafluorobenzene (Figure 2­4c).
Recent theoretical studies have suggested that the shift in electron density upon
fluorination is more localized to the carbon skeleton than the π clouds.38, 39 Nevertheless,
it is clear that the complementary charge distributions of benzene and
hexafluorobenzene drive them to associate in the face­face stacked geometry when
mixed, rather than the preferred T­shaped or offset­stacked geometries of the individual
components. Importantly, these types of aromatic­aromatic contacts are commonly
observed motifs in protein tertiary structure and serve as potential targets for protein
engineering, medicinal chemistry, and materials science applications.
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2.1.4  Fluorinated aromatic amino acids – applications in protein
�
engineering
A structural survey of the Protein Data Bank (PDB) has revealed a large
abundance of native aromatic residues engaged in potentially important polar–π
interactions. A polar–π interaction is defined as any interaction between the π face of an
aromatic residue and a charge, partial charge, dipole or another quadrupole. For
example, there appears to be 1 energetically significant cation–π interaction (where an
aromatic sidechain Trp, Tyr, or Phe packs against an Lys or Arg) every 77 residues.40 
Approximately 60% of aromatic residues are found to form a close contact with another
aromatic sidechain, which hints at the thermodynamic significance of π–π interactions.
Although polar–π interactions have been a subject of investigation for decades, their
significance had not been directly examined in protein systems until relatively recently.37 
Given the unique properties of fluorinated aromatics and the prevalence of aromatic
contacts in protein structure, fluorination of aromatic residues presents an ideal
approach for probing polar–π interactions due to its ability to afford small steric yet
large electronic perturbations. Efforts towards this goal are described in greater detail in
the following sections.
Cation–π interactions
Perhaps the most well studied polar–π contact is the cation–π interaction. Today,
these interactions are known to be employed by numerous signaling proteins such as
acetylcholine receptors and chromodomains that recognize methylated histones.41, 42 
Early work investigating this type of molecular association originated in the gas phase,
where researchers demonstrated that benzene actually has an equal affinity for K+ and
H2O.43­45 It was hypothesized that cation–π interactions could play an important role in
the ability of neuronal receptors to recognize and bind their cationic ligands. Pioneering
work by Dougherty and coworkers has demonstrated the power of fluorination in directly
26
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investigating the energetic scale of these cation–π interactions.46 Dougherty
hypothesized that increasing fluorination would reduce the ability of Trp to effectively
bind cations deactivate the mutant receptors. To test this hypothesis, a series of
fluorinated Trp analogues were introduced into nAChR of Xenopus oocytes. Activation of
the nAChR variants was monitored using electrophysiology measurements of single
channel conductance. The ligand concentration (logEC50) should correlate linearly with
the calculated cation binding potentials of the Trp analogues (Figure 2­5).
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Figure 2­5. Examining cation–π interactions using fluorinated aromatic amino acids. (a)
Cartoon representation of the nicotinic acetylcholine receptor (nAChR) illustrating its
significant structural features. The agonist binding site (grey oval) is depicted with the
nearby aromatic residues from the α and δ subunits (inset); (b) Plot of logEC50 for nAChR
activation against the calculated cation–π binding potential for Trp and its fluorinated
analogues. A clear correlation between nAChR function and cation–π binding ability is
apparent. Images have been reproduced from Reference 46.
The measured relative binding affinities enabled the first direct assessment of the
energetic scale of cation–π interactions in proteins: tetrafluorination of Trp reduces the
28
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EC50 value by 100 fold, which corresponds to approximately 3 kcal mol–1 in binding free
energy. Recently, Dougherty and coworkers have expanded their studies to a variety of
47­54 ligand­gated ion channels41, and G­protein coupled receptors (GPCRs).55 These
studies have demonstrated that Tyr56 and Phe57 are also capable of participating in
cation–π interactions. Furthermore, the site­specific incorporation of fluorinated amino
acids has allowed for “hotspots” within a cation binding pocket to be identified. The
importance of certain residues within an aromatic cluster suggests that a geometric
requirement for the establishment of cation–π interactions exists, but more conclusive
evidence must be obtained.
The energetic scale of cation–π interactions has also been estimated by directly
measuring the association of the bromodomain with its substrate, a trimethylated lysine
on the histone.42 By comparing the binding of the bromodomain to the trimethylated
substrate and its neutral isostere, Waters and coworkers have determined that a cation– 
π interaction can stabilize the bromodomain­substrate complex by up to –3 kcal mol–1, a
result that agrees quite well with the work of Dougherty. From these data it is clear that
cation–π interactions are energetically significant and play critical roles in a myriad of
protein structural and functional motifs.
Offset­stacked and edge­face aromatic interactions
Experimental and theoretical studies have implicated the edge­face and offset­
stacked geometries as the preferred packing modes for two interacting benzene
molecules (Figure 2­4b).31 The aromatic residues of proteins also prefer to interact in
these geometries, and the face­face stacked geometry is rarely observed.58, 59 It is
important to note, however, that within proteins aromatic pairs display a continuous
distribution of cross angles, from 0­90°, instead of being strictly parallel (offset­stacked)
or perpendicular (edge­face) as in the benzene crystal structure. Therefore, we will
discuss these types of aromatic contacts together.
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Inspired by the work of Dougherty and others, in the early 2000s Waters and
­
coworkers utilized pentafluorophenylalanine (Z) to examine the role of π–π interactions
in stabilizing protein secondary structure.60 By incorporating aromatic pairs into a host
Ala–Lys peptide, they showed that a Phe­Phe pair at the i and i + 4 positions stabilizes
the α­helix by as much as –0.8 kcal mol–1. In contrast, a Phe­Z pair stabilizes the α­helix
to a lesser extent, only up to –0.55 kcal mol–1. These data suggest that the Phe­Phe
interaction is predominantly electrostatic instead of hydrophobic, since Z is significantly
more hydrophobic than Phe (LogP values of 3.31 and 2.54, respectively). Molecular
modeling demonstrates that the Phe sidechains are permitted to interact in either the
edge­face or offset­stacked geometries (the face­face stacked geometry is actually not
feasible for residues in the i and i + 4 positions of an α­helix). Although the Z sidechain
possesses a lower α­helical propensity than Phe (a phenomena that still remains poorly
understood)60, 61, the use of a double mutant cycle still allows for the accurate assessment
of the aromatic­aromatic interaction. Waters and coworkers have also discovered that a
Phe­Phe pair oriented in the edge­face geometry can stabilize a β­hairpin by up to –0.55
kcal mol–1.62 These data clearly support the energetic significance of aromatic­aromatic
interactions and their ability to influence protein structure and function.
In addition to Gellman and co­workers63, our group has attempted to elucidate
the energetic significance of aromatic packing inside a protein core by introducing highly
fluorinated Phe analogues into the villin headpiece subdomain (HP35), one of the
smallest known globular domains that forms a stable structure. This 35­amin acid
peptide folds into three α­helices, which wrap around each other to form an aromatic
core (Figure 2­6). The core Phe residues pack against each other in the edge­face
geometry: the edge of Phe10 contacts the π­face of Phe6 with a dihedral angle of 61°,
while the edge of Phe6 packs against the face of Phe17 with a cross angle of 92°.
Curiously, individual mutations at these positions have distinct effects on HP35 stability.
30
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Gellman and workers discovered that, while the F10Z mutation stabilizes HP35, the F6Z 
and F17Z mutations are actually destabilizing.64 All three residues are buried in the core 
of the peptide, so the contribution of hydrophobicity to the observed difference should be 
minimal. Helical propensity differences should also be negligible, as all Phe residues are 
oriented in α­helical conformations. 
 
 
Figure 2­6. Fluorinated aromatic amino acids as tools for examining edge­face interactions. 
(a) Cartoon representation of HP35 (PDB: 1YRF) with the aromatic residues Phe6, Phe10, 
and Phe17 shown in the hydrophobic core (orange). Hydrogen atoms thought to be engaging 
in favorable edge­face interactions have been colored blue; (b) Graph summarizing the 
thermodynamic importance of edge­face interactions to the stability of HP35 (ΔGunfold). ESP 
maps for the mutated sidechains are shown for added clarity. In comparison with F10Z, 
F10Zo is more stable by –1.1 kcal mol–1 because the edge­face interaction with F6 is retained. 
 
Our group hypothesized that these F­Z mutations elicit position­dependent 
stability changes because they disturb the edge­face interactions between the core 
aromatic residues. Using a set of tetrafluorinated phenylalanines (denoted Zx, where x 
refers to the position of the proton in the aromatic ring), this hypothesis was tested 
(Figure 2­6b). Notable, F10Zo is more stable than F10Z by –1.1 kcal mol–1 presumably 
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because F10Zo retains the favorable edge­face interaction between Phe10 and Phe6,
whereas this interaction in eliminated in the F10Z mutant. By retaining the Phe6­Phe17
edge­face contacts, F6Zp is also more stable than its fully fluorinated counterpart F6Z by
–0.3 kcal mol–1.64 Importantly, the stability afforded by an edge­face interaction appears
to be environment­dependent, which makes sense given its electrostatic nature.
Overall, these results hint at the potential for fluorinated aromatics to be useful
tools in protein engineering, but the energetic scale and scope of these interactions needs
to be studied further. Towards that end, we have systematically investigated the effect of
fluorination on the energetics of π–π stacking interactions and their applications in
mediating protein self­assembly. Our efforts towards this goal will be described the next
section.
2.2 	 Probing the effects of fluorination on the stability of π­π stacking
interactions in a soluble protein core
Previous studies using both computational and small molecule model systems
have shown that face­face (π–π) stacking of benzene molecules is unfavorable.34, 65 
Furthermore, an analysis of reported protein structures shows that the π–π stacking
geometry is scarcely seen.58 These observations are presumably due to the repulsion
between the electron­rich π clouds. As previously mentioned, however, aromatic
moieties possessing opposing quadrupoles, such as benzene and hexafluorobenzene
(Figure 2­4) prefer to interact in the face­face stacked geometry. The phenyl­
perfluorophenyl pair has been utilized as a supramolecular synthon to program
66, 67 molecular packing in crystals36, and has also been used to control the
stereoselectivity of polymerization reactions.68, 69 Because π–π stacked aromatic pairs are
rarely observed in native protein structures, this mode of association offers intriguing
32
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potential for programming protein­protein interactions and affording self­assembling 
peptide materials. Efforts towards this goal are described in the following sections. 
2.2.1  Synthesis of fluorinated phenylalanine derivatives 
A systematic investigation of the effects of fluorination on the stability of π­π 
stacking interactions requires an extensive library of fluorinated aromatic amino acids, 
within which the extent and pattern of fluorination should be widely varied (Figure 2­
7).  
 
 
Figure 2­7. Selected fluorinated analogues of phenylalanine (Phe, F) that have been 
incorporated into peptides. All of the corresponding Fm0c­protected L­amino acids have 
either been purchased or synthesized and have been incorporated into peptide via standard 
SPPS protocol. Each sidechain has been named according to the number of fluorine 
substitutions and the pattern of fluorination. For example, F35F refers to the sidechain 3,5­
difluorophenylalanine. This nomenclature will be used throughout our discussion. 
 
With the exception of the tetrafluorophenylalanine series, all fluorinated amino 
acids used in this study were commercially available in either the free amino acid or 
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Fmoc­N­protected forms. We have previously reported the synthesis of Fmoc­N­2,3,4,5­

tetrafluorophenylalanine (Fmoc­Zo) and Fmoc­N­2,3,5,6­tetrafluorophenylalanine 
(Fmoc­Zp) using the Seebach chiral auxiliary.64 Despite the successful generation of these 
tetrafluorphenylalanines, this synthesis requires harsh acid and base hydrolysis 
conditions that could potentially scramble the stereochemistry of the desired 
enantiomer. In order to circumvent this problem, we have developed an alternate 
synthesis using the Schöllkopf chiral auxiliary, which is easily prepared in gram 
quantities through the cyclization of the D­Val–Gly dipeptide and subsequent ethylation 
by Et3OBF4.70 We first attempted to synthesize Fmoc­N­2,3,4,6­tetrafluorophenylalanine 
(Fmoc­Zm) using this route, since its synthesis had not been previously reported 
(Scheme 2­1).  
 
 
Scheme 2­1. Synthesis of Fmoc­Zm 5 via the Schöllkopf chiral auxiliary 2. Conditions: (a) 
EtO3BF4, DCM, 25 °C, 72 hrs; (b) 1) nBuLi, THF, ­78 °C, 30 mins; 2) 2,3,4,6­
tetrafluorobenzyl bromide, ­78 °C, 2 hrs; (c) 2 N HCl, THF, 0 °C to 25 °C, 2hrs; (d) 1) 1 N 
NaOH, EtOH, 50 °C, 2 hrs; 2) 10% Na2Co3, CH3CN, Fmoc­Osu, 0 °C to 25 °C, 45 mins. 
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Following deprotonation by n­butyllithium (nBuLi), the chiral auxiliary was 
alkylated with the desired 2,3,4,6­tetrafluorobenzyl bromide to give the amino acid 
precursor in high yield and diastereoselectivity. The correct diastereomer was confirmed 
through a 2D 1H­1H NOESY experiment (Figure 2­8). Subsequent acid and base 
hydrolysis followed by Fmoc protection yielded the target amino acid in high overall 
yield and enantiopurity. Although we have only synthesized the tetrafluorophenylalanine 
series with this scheme, it can be utilized to obtain other fluorinated phenylalanine 
derivatives from their corresponding benzyl bromide precursors. 
  
 
Figure 2­8. The 2D 1H­1H NOESY of 5 proves the formation of the correct diastereomer, 
which is mediated by the Schöllkopf chiral auxiliary. (a) Spectra showing the crosspeaks for 
Hb and Hc with Ha; (b) Model generated in Spartan 2010 shows the spatial proximity of Ha 
to Hb and Hc, all within 3 Å of each other. In the other diastereomer, these protons are no 
longer close enough in space to have NOEs. 
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2.2.2  The four­helix dimer α2D as a model peptide
In order to quantitatively assess π–π stacking interactions in proteins we have
employed the designed peptide α2D as a model system (Figure 2­9). Developed by
DeGrado and coworkers, α2D is a soluble, 35­residue polypeptide that folds into a
dimeric, four­helix bundle.71 This peptide provides three key advantages as a model
system for investigating π–π stacking. First, the peptide is easily synthesized through
solid phase peptide synthesis (SPPS), allowing access to a large library of single and
double mutants containing fluorinated aromatics.
36
­
 Figure 2­9. Using fluorinated Phe analogues to investigate the energetics of face­face 
stacking interactions in the model peptide α2D. (a) Cartoon representation of the α2D 
homodimer (PDB: 1QP6) highlighting the two face­face stacked Phe pairs in the core of the 
folded dimer (colored orange). The Phe29 residue of one monomer stacks against the Phe29 
of the other monomer; (b) (Top) Primary sequence of α2D showing the mutation sites at the 
10 and 29 positions; (Bottom) Inset showing the stacked pairs being examined in each α2D 
series (F, X) and (X, X) compared with the native (F, F). Here, (F, Z) and (Z, Z) are 
shown as examples; (c) Representative thermal denaturation curve for  (Zo, Zo) at 20 µM, 
illustrating the two­state unfolding behavior characteristic of the α2D variants; (d) Circular 
dichroism (CD) spectra of (Zm, Zm) at 20µM, demonstrating the reversible 
folding/unfolding behavior characteristic of α2D. Curves are within the reported error for 
each data point collected. 
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Additionally, the folded dimer of α2D contains a core of aromatic residues, with
the F10 residue from one monomer stacking against the F29 residue of the second
monomer (Figure 2­9a). Any potential repulsive forces that exist between the stacked
phenylalanines are compensated for by the folding free energy of the peptide. The rigid
core of the dimer also preorganizes the Phe sidechains into the desired face­face
geometry, mitigating entropic costs associated with the interaction. As a result, the
relative stabilities of the folded peptides should correlate well with the stabilities of the
stacked aromatic pairs. Finally, α2D exhibits highly cooperative, reversible two­state
folding behavior that allows for facile thermodynamic analysis (Figure 2­9c­d).
Because the thermal stability of the α2D dimer is dependent on the peptide
concentration, we can determine a peptide’s folding free energy by applying the van’t
Hoff equation (Experimental Procedures).72 For ease of discussion, the following
naming system will be used for all α2D mutants: each peptide is referred to according to
the residues at its 10 and 29 positions (F10X, F29X). For example, wild­type α2D will
be named (F, F), and the pentafluorophenylalanine double mutant will be named (Z,
Z).
2.2.3  Synthesis and characterization of α2D variants
All α2D variants were synthesized using Fmoc­based SPPS conditions and the
commercially available Fmoc­Gly­Wang resin. Fmoc­removal was achieved by mixing
with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for five minutes at
room temperature. For each coupling step, five equivalents of the desired amino acid
were activated by O­benzotriazole­N­N­N’­N’­tetramethyl­uronium­hexafluoro­
phosphate (HBTU) and N­methylmorpholine (NMM) for two minutes prior to coupling.
The activated amino acid was then mixed with resin for thirty minutes at room
temperature to achieve amide bond formation. For the coupling of all fluorinated Phe
analogues, three equivalents were activated with HBTU and mixed with resin for 1.5 hrs.
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Resin cleavage and sidechain protecting group removal were achieved simultaneously by
mixing resin­bound peptide with a solution of 94% TFA, 2.5% H2O, 2.5% EDT, and 1%
TIS at room temperature for 2 hrs. Ether precipitation followed by centrifugation yielded
the crude product. All peptides were then purified using both prep scale RP­HPLC and
size exclusion chromatography. After purification, all α2D variants were identified and
assessed to be ≥ 95% pure through LC­MS analyses (Table 2­1).
Table 2­1. ESI­MS characterization of α2D variants
Peptide MW Calculated (Da) MW Found (Da)
(F, F)
(F2F, F2F)
(F3F, F3F)
(F4F, F4F)
(F34F, F34F)
(F35F, F35F)
(F245F, F245F)
(F345F, F345F)
(Zo, Zo)
(Zm, Zm)
(Zp, Zp)
(Z, Z)
(F, F245F)
(F, F345F)
(F, Zo)
(F, Zp)
(F, Z)
(Z, F)
(Cha, F)
(F, Cha)
(Z, Cha)
(Cha, Cha)
(F, F, hC)
(Z, Z, hC)
(F345F, F345F, hC)
(Cha, Cha, hC)
4247.9
4283.9
4283.9
4283.9
4319.9
4319.9
4355.8
4355.8
4391.8
4391.8
4391.8
4427.8
4301.9
4301.9
4319.9
4319.9
4337.8
4337.8
4253.9
4253.9
4343.9
4260.0
4229.8
4408.8
4336.9
4241.9
4248.0
4285.7
4282.2
4285.4
4321.3
4321.2
4357.7
4354.8
4391.0
4392.2
4390.6
4426.0
4304.6
4305.5
4323.0
4322.6
4337.0
4337.1
4256.8
4256.0
4347.0
4262.0
4230.6
4410.9
4338.6
4241.0
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2.2.4  Thermodynamic analyses of α2D double mutants
In order to examine the physical properties important for aromatic stacking
interactions, we first generated a series of α2D double mutants (X, X) containing a large
variation in the extent and pattern of fluorination (Figure 2­7). The thermodynamic
stability of all peptide variants was assessed using circular dichroism (CD). All peptides
display CD spectra with local minima at 220 nm and 208 nm, indicating the expected α­
helical secondary structure. Because α2D exists as a dimer when folded, the thermal
stability should be dependent on the peptide concentration. After conducting thermal
denaturation experiments at different concentrations, the thermodynamic parameters of
each peptide were obtained through van’t Hoff analyses (Table 2­2).
Table 2­2. Summary of thermodynamic parameters for α2D (X, X) double mutants
Peptide Tm (°C) [a]
ΔHf 
(kcal mol–1) [b]
ΔGf 
(kcal mol–1) [c]
ΔΔGf 
(kcal mol–1) [d]
(F, F) 28.9 –28.4 ± 2.6 –5.9 ± 0.1 ­­
(F2F, F2F) 39.7 –25.0 ± 3.9 –6.9 ± 0.1 –1.0
(F3F, F3F) 46.9 –51.4 ± 5.9 –8.3 ± 0.2 –2.4
(F4F, F4F) 39.8 –43.6 ± 5.2 –7.1 ± 0.1 –1.2
(F34F, F34F) 57.8 –60.7 ± 7.4 –10.5 ± 0.5 –4.6
(F35F, F35F) 55.2 –48.2 ± 5.8 –9.3 ± 0.3 –3.4
(F245F, F245F) 63.7 –57.4 ± 2.4 –11.2 ± 0.2 –5.3
(F345F, F345F) 72.1 –59.7 ± 5.0 –12.8 ± 0.5 –6.9
(Zo, Zo) 75.9 –51.0 ± 3.5 –12.4 ± 0.4 –6.5
(Zm, Zm) 65.0 –60.8 ± 3.3 –11.7 ± 0.3 –5.8
(Zp, Zp) 52.2 –41.1 ± 2.3 –8.7 ± 0.1 –2.8
(Z, Z) 78.3 –50.1 ± 3.1 –12.6 ± 0.4 –6.7
[a] Peptide concentration of 20 µM; all measurements within ± 1 °C. [b] Calculated by
plotting vs. lnK for different peptide concentrations and using the van’t Hoff
equation [c] Determined at 37 °C, peptide concentration of 20 µM.
[d] ΔΔGf = ΔGf (X, X) – ΔGf (F, F) 
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The α2D double mutants display a wide range of stabilities, with melting points
(Tm) from 29 °C to 78 °C and folding free energies (ΔGf) from –5.9 to –12.8 kcal mol–1.
(Table 2­2) Despite the increased steric bulk, fluorination of the core Phe residues
appears to be well tolerated by α2D, as all fluorinated mutants show an increase in
stability compared with the wild type (F, F). In fact, complete fluorination of the Phe
core residues dramatically increases the stability of α2D by about –6 kcal mol–1, with a Tm 
increase of about 50 °C for (Z, Z). The significant increase in stability caused by two F­
to­Z mutations is expected, as fluorination is known to increase hydrophobicity while
simultaneously introducing minimal steric perturbation. For a single F­to­Z mutation,
we have estimated the contribution of increased hydrophobicity to be approximately –1.5
kcal mol–1. We have further investigated the hydrophobic contribution of an F­to­Z
mutation in the model peptide PinWW, the details of which will be discussed in a later
section.
In addition to its effect on hydrophobicity, varying the degree and pattern of
fluorination affords a wide distribution in other physical properties of the sidechains,
such as the surface area, dipole moment, and quadrupole moment. As previously
described, the α2D (X, X) double mutants contain two pairs of stacked fluorinated Phe
residues in the core of the folded dimer (Figure 2­9). Thermodynamic analysis of this
(X, X) series therefore allows us to directly correlate the peptides’ folding free energies
with the aforementioned physical properties of each Phe analogue. We first examined the
effect of sidechain hydrophobicity on the peptide stability by plotting calculated LogP
values against the calculated folding free energies (Figure 2­10a). The homodimer
stability exhibits a positive but moderate correlation (R2 = 0.67) with the sidechain
hydrophobicity, indicating that additional physical properties must play a role in the
stability of the stacked aromatic residues. A similarly positive correlation (R2 = 0.68) was
observed when plotting the sidechain surface area against the peptide folding free energy
41
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(Figure 2­10b). This result was not surprising since hydrophobicity and surface area
often correlate with each other. These data indicate that factors other than the sidechain
hydrophobicity must contribute to the stability of the α2D variants.
42
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 Figure 2­10. Using Phe analogues to investigate how the extent and pattern of fluorination 
affect the energetics of π–π stacking interactions in the model peptide α2D (X, X) series.  (a) 
Plot showing a positive correlation (R2 = 0.67) between the sidechain hydrophobicity (LogP) 
and the peptide folding free energy (ΔGf); (b) Plot showing a positive (R2 = 0.68) correlation 
between sidechain surface area and peptide folding free energy (ΔGf); (c) Plot showing a 
positive (R2 = 0.51) correlation between sidechain dipole moment and peptide folding free 
energy (ΔGf); (d) Plot showing an excellent (R2 = 0.93) correlation with peptide folding free 
energy (ΔGf) when both sidechain hydrophobicity (LogP) and dipole moment are combined 
into a single synthetic parameter (a linear combination of the individual parameters where 
SLogP is the slope of the LogP fit and SDipole is the slope of the dipole fit). 
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Upon closer examination, the α2D mutants containing Phe analogues that differ
only in the pattern of fluorination display remarkable discrepancies in their stabilities.
For example, the tetrafluorophenylalanine mutants (Zo, Zo), (Zm, Zm), and (Zp, Zp)
possess folding free energies that differ by as much as 4 kcal mol–1 despite having
fluorinated Phe residues of comparable size and hydrophobicity. Their relative dimer
stabilities correlate well with the magnitudes of the dipole moments of the fluorinated
Phe sidechains. A similar trend is also seen for the trifluorinated mutants, where (F345F,
F345F) is more stable than (F245F, F245F) by ­1.6 kcal mol–1. The (F345F, F345F) mutant
actually exhibits the most favorable folding free energy of all the double mutants
investigated, presumably due to the F345F residue having the largest dipole moment
(3.50 Debye) of the fluorinated Phe sidechains (Table 2­3). Notably, global analysis of
all α2D variants shows a positive correlation (R2 = 0.51) when plotting the sidechain
dipole moment against the α2D folding free energy (Figure 2­10c), which further
suggests that dipole­dipole interactions may contribute significantly to the stability of π– 
π stacking interactions in proteins.
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Table 2­3. Calculated parameters for fluorinated Phe sidechain analogues
­
Sidechain LogP
Surface Area
(Å2)
Dipole Moment
(Debye)
SLogPLogP + SDipoleDipole
F 
F2F 
F3F 
F4F 
F34F 
F35F 
F245F 
F345F 
Zo 
Zm 
Zp 
Z
2.54
2.68
2.68
2.68
2.84
2.84
3.00
3.00
3.15
3.15
3.15
3.31
134.66
140.10
140.58
140.59
146.45
146.49
151.86
152.30
157.69
157.15
157.31
162.09
0.26 
1.43
1.78
1.89
3.04
1.94
1.97
3.51
3.06
1.87
0.52
2.07
–21.21
–24.45
–25.23
–25.51
–28.92
–27.03
–28.35
–31.27
–31.63
–29.26 
–26.88
–31.15
R2 (X, X)
R2 (F, X)
0.67
0.05
0.68
­­
0.51
0.66 
0.93
­­
Because these data indicate that both hydrophobicity and dipole­dipole
interactions are important determinants of π­π stacked pair stability, we have plotted a
synthetic parameter that takes into account both hydrophobicity and dipole moment
against the folding free energy. This synthetic parameter is the linear combination of the
sidechains’ LogP values and the dipole moments. A much­improved correlation was
observed (R2 = 0.93) when taking into account both hydrophobicity and dipole moment
(Figure 2­10d). These results, while highlighting the complex nature of π­π stacking
interactions, illustrate that the relative stabilities of the α2D double mutants can be
reliably predicted by taking into account two sidechain physical properties, notably the
hydrophobicity and dipole moment of the fluorinated Phe analogues.
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2.2.5  Thermodynamic analyses of α2D single mutants
After confirming the significant contribution of dipole­dipole interactions to the
stability of stacked aromatic residues, we then sought to investigate how the dipole
moment affects the ability of a fluorinated Phe residue to stack with a native Phe. Given
the dipole moment trend observed with the α2D double mutants, we hypothesized the
dipole­induced dipole interactions could contribute significantly to the stability of a π­π
stacked aromatic moiety. Towards this end, we have generated a small library of α2D
single mutants where the native Phe was preserved in the 10 position, while the residue
in position 29 was mutated to fluorinated analogues. Upon folding, a (F, X) homodimer
will position the X29 sidechain of one monomer to stack with Phe10 residue of the other
monomer. These α2D mutants have been named the (F, X) series (Figure 2­9).
Table 2­4. Summary of thermodynamic parameters for α2D (F, X) single mutants
Peptide Tm (°C) [a]
ΔHf 
(kcal mol–1) [b]
ΔGf 
(kcal mol–1) [c]
ΔΔGf
(kcal mol–1) [d]
(F, F) 28.9 –28.4 ± 2.6 –5.9 ± 0.1 ­­
(F, F245F) 55.4 –61.5 ± 5.2 –10.1 ± 0.3 –4.2
(F, F345F) 63.1 –61.5 ± 1.3 –11.4 ± 0.1 –5.5
(F, Zp) 56.6 –51.3 ± 1.4 –9.7 ± 0.1 –3.8
(F, Zo) 68.6 –64.2 ± 2.8 –12.6 ± 0.3 –6.7
(F, Z) 62.5 –53.7 ± 3.1 –10.9 ± 0.2 –5.0
[a] Peptide concentration of 20 µM; all measurements within ± 1 °C. [b] Calculated by
plotting vs. lnK for different peptide concentrations and using the van’t Hoff
equation [c] Determined at 37 °C, peptide concentration of 20 µM.
[d] ΔΔGf = ΔGf (X, X) – ΔGf (F, F) 
The stabilities of these (F, X) single mutants should reveal the fluorinated Phe
analogues that are best suited for targeting a Phe through a π–π stacking interaction. Not
surprisingly, all (F, X) mutants are more stable than (F, F), an expected result even
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when only hydrophobicity is considered (Table 2­4). Further comparison of the (F, X)
�
folding free energies reveals that (F, Zo) forms the most stable dimer, more stable that
(F, Z) by a significant margin (–1.7 kcal mol–1). This result is particularly noteworthy
because the Z sidechain is more hydrophobic than Zo and also possesses a more positive
quadrupole moment for stacking with Phe. When considering sidechain dipole moments,
however, Zo (3.05 Debye) should be able to engage in a stronger dipole­induced dipole
interaction with Phe compared with Z (2.07 Debye). A comparison of the α2D singles
mutants (F, Zo) and (F, Zp) clearly demonstrates the powerful contribution of dipole­
induced dipole interactions to the stability of π­π stacking pairs. These mutants, while
only differing in the position of a single fluorine atom, differ in folding free energy by a
remarkable 3 kcal mol–1 (Table 2­4). This disparity in free energy is presumably due to
the large difference in the dipole moments of the Z0 (3.05 Debye) and Zp (0.52 Debye)
sidechains, since both the hydrophobicity and the quadrupole moments should be
identical. This trend is also observed with the (F, F245F) and (F, F345F) mutants.
Furthermore, when plotting against the folding free energy, a notably more positive
correlation is observed with the dipole moment (R2 = 0.66) than with the LogP (R2 =
0.05) (Figure 2­11). Overall, these data indicate that, when engaging Phe in a π–π
stacking interaction, an optimal combination of hydrophobicity and dipole moment is
essential to maximizing its strength.
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 Figure 2­11. Using Phe analogues to investigate how the extent and pattern of fluorination 
affect the ability to stack favorably with a native Phe residue in the model peptide α2D (F, X) 
series. (a) Cartoon of the α2D (F, X) structure, with F10 residues (orange) and F29 residues 
(blue) shown for clarity. The F­Z stacking pair is shown as an example. Thermodynamic 
analysis illustrates that the Zo residue is the best packing partner for Phe.  (b) Plot showing 
no correlation (R2 = 0.05) between the sidechain hydrophobicity (LogP) and the peptide 
folding free energy (ΔGf); (c) Plot showing a positive (R2 = 0.66) correlation between 
sidechain surface area and peptide folding free energy (ΔGf). These data clearly illustrated 
the importance of dipole­induced dipole interactions when targeting Phe with a fluorinated 
analogue. 
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2.2.6 	 Summary of π­π stacking interactions
Herein we present, to the best of our knowledge, the first systematic investigation
of the energetics of aromatic face­face stacking interactions in the context of the protein
model system.73 Through the examination of the α2D (X, X) and (F, X) series we have
clearly demonstrated the range, hierarchy, and inherent complexity of π­π stacking
energetics. Systematic analysis of the (X, X) dimer folding free energies indicates that
physical properties other than hydrophobicity play an integral role in the stability of π­π
stacked aromatics. Our results reveal the surprisingly large contributions of dipole­
dipole and dipole­induced dipole interactions to the stability of aromatic pairs stacked in
the face­face geometry. These results are consistent with recent publications from both
experimental and theoretical perspectives that also support the significance of dipole
contributions to aromatic stacking.74­76 From the α2D (F, X) series we have learned that
the comparable importance of hydrophobicity and dipole moment make Zo the best
residue for targeting native Phe residues through π–π stacking. For example, this finding
is particularly important for the design of enzyme inhibitors where aromatic residues
exist in the enzyme binding pocket.77, 78 Furthermore, the electrostatic components of
these noncovalent interactions offer intriguing possibilities as mediators of highly
specific protein self­assembly.
2.3 	 Stacked fluoroaromatics as facilitators of specific protein self­
assembly
Supramolecular synthons that direct molecular association are highly desirable
for the design of self­assembled materials and foldamers that interact with biological
systems.79­83 With a few exceptions, much work in the area of peptide and protein design
has utilized polar groups to afford structural specificity through hydrogen bonding and
salt bridge formation.83 Although ubiquitously observed in protein structure58, 59,
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aromatic residues and their contacts have rarely been used in protein design, presumably
­
due to our incomplete understanding of their energetics.63, 84, 85 With our improved
understanding of the importance of electrostatics to the energetics of π­π stacked
aromatic moieties, we hypothesized that Phe and/or its fluorinated analogues could be
utilized to dictate the dimerization preferences of multicomponent mixtures of α2D
variants based on the physical mechanism. Because all the aromatic residues are
sequestered in the core of the dimer regardless of whether or not they are fluorinated,
the hydrophobic effect should not play a role in preferential dimer formation. Rather,
preferential self­assembly should be driven by the specific electrostatic interactions that
exist between the core stacked residues.
2.3.1 	 Complementary interactions – specific heterodimerization induced
by F­Z stacking interactions
As previously discussed, it is well known that benzene and hexafluorobenzene
interact favorably due to their opposing quadrupole moments.86 Our lab hypothesized
that this favorable π–π interaction, when existing between stacked F and Z residues in
the core of α2D, should be able to facilitate heterodimer formation between a mixture of
(F, F) and (Z, Z) despite both existing as stable homodimers. For ease of discussion,
α2D homodimers will be named as (X, X)2 and α2D heterodimers will be named as (X,
X)­(X, X), where each parentheses denotes a monomeric unit of the folded dimer. For
example, since the native α2D (F, F) folds into a stable homodimer, its oligomeric state
will be named (F, F)2 for this discussion. As expected, a mixture of (F, F) and (Z, Z)
exchanges completely from folded (F, F)2 and (Z, Z)2 homodimers to give (F, F)­(Z, Z)
heterodimers.87 The relative populations of (F, F)2, (Z, Z)2, and (F, F)­(Z, Z) can be
easily monitored using fluorescence resonance energy transfer (FRET), gel filtration, and
1H­NMR (Figure 2­12a).87 
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 Figure 2­12. Highly specific heterodimer formation mediated by quadrupole interactions. 
(a) Cartoon depicting the specific heterodimer formation between the α2D variants (F, F) 
and (Z, Z). This exclusive heterodimer formation has been confirmed using disulfide 
crosslinking, gel filtration, FRET, 1H­NMR and 19F­NMR. Hydrogen atoms are white, while 
fluorine atoms are colored red; (b) The double mutant cycle used to estimate the energetic 
scale of the F­Z stacking interaction. The ΔGf for each peptide variant is shown. The strength 
of the F­Z quadrupole interaction is represented as ΔGquad and energetic contributions from 
all other factors as ΔGother. 
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Since this homodimer–heterodimer equilibrium is not driven by the hydrophobic
effect, preference for the heterodimer is presumably driven by the favorable π­π
interactions between the quadrupoles of the F and Z sidechains. Employing double
mutant cycle analysis, a useful approach for estimating the energetic scale of pairwise
interactions88­90, we have estimated the F­Z cross affinity to be approximately ­1.0 kcal
mol–1 (Figure 2­12b). The strength of a stacked F­Z pair is comparable to that of a weak
hydrogen bond.
Encouraged by this discovery, we then hypothesized that aromatic interactions
that possess different electrostatic mechanisms (for example, quadrupole interactions vs.
dipole­dipole interactions) should be able to direct orthogonal self­assembly of
multicomponent mixtures. More specifically, a mixture of (F, F)2, (Z, Z)2, and (F345F,
F345F)2 should equilibrate to form exclusively (F­F)–(Z, Z) heterodimer and (F345F,
F345F)2 homodimer, a process driven by quadrupole interactions and dipole­dipole
coupling, respectively. To test this hypothesis, however, we needed to utilize a method
that would allow for the quantitative examination of a three­component mixture. We
chose to analyze the mixture using a disulfide crosslinking experiment. Towards this
end, a series of mutants containing the thiol homocysteine (hCys, hC) were prepared.
This series will be designated (X, X, hC), with the hC mutation at the His30 position.
2.3.2  Synthesis, characterization, and thermodynamic analyses of thiol­
containing α2D variants
All α2D (X, X, hC) variants were synthesized using Fmoc­based SPPS conditions
and the commercially available Fmoc­Gly­Wang resin. Fmoc­removal was achieved by
mixing with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for five
minutes at room temperature. For each coupling step, five equivalents of the desired
amino acid were activated by O­benzotriazole­N­N­N’­N’­tetramethyl­uronium­
hexafluoro­phosphate (HBTU) and N­methylmorpholine (NMM) for two minutes prior
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to coupling. The activated amino acid was then mixed with resin for thirty minutes at
room temperature to achieve amide bond formation. The coupling of Fmoc­hCys
followed an identical protocol to the proteinogenic amino acids (the hCys sidechain is
Trt­protected like Cys). For the coupling of Fmoc­Z and Fmoc­F345F, three equivalents
were activated with HBTU and mixed with resin for 1.5 hrs. Resin cleavage and sidechain
protecting group removal were achieved simultaneously by mixing resin­bound peptide
with a solution of 94% TFA, 2.5% H2O, 2.5% EDT, and 1% TIS at room temperature for 2
hrs. Ether precipitation followed by centrifugation yielded the crude product. All
peptides were then purified using both prep scale RP­HPLC and size exclusion
chromatography. After purification, all α2D variants were identified and assessed to be ≥
95% pure and in the reduced form through LC­MS analyses (Table 2­1).
2.3.3 	 Exclusive self­assembly from multicomponent mixtures – analysis
by disulfide crosslinking
We have previously shown that the F­Z stacking pair affords dimerization
specificity in α2D.87 It follows that stacked pairs possessing distinct modes of interaction
should also exhibit inherent association preferences. Unfortunately, a mixture of (F, F,
hC), (Z, Z, hC), and (F345F, F345F, hC) will in principle give six dimeric species if
dimerization is completely or partially random. The analysis of such a system may prove
to be complicated and requires an assay that allows for easy separation and identification
of each species. For analyzing the thermodynamic equilibrium of this three­component
mixture, a disulfide crosslinking experiment provides key advantages. First, in the (X,
X, hC) mutants the C2 symmetry of the folded α2D dimer positions two hCys side chains
in close enough proximity to be covalently linked when exposed to oxidative conditions
(Figure 2­13).
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 Figure 2­13. The α2D (X, X, hC) series introduces the H30hC mutation for disulfide 
crosslinking applications. (a) Primary sequence showing the location of the hC mutation; (b) 
Upon examination of the folded dimeric structure, the His30 residues of each monomer are 
positioned in close proximity to one another (inset). Incorporation of homocysteine (hCys, 
hC) in the H30 position allows for oxidative crosslinking of a population of α2D dimers at 
equilibrium. 
 
The insertion of hCys also has a negligible effect on the structure and stability of 
α2D (Figure 2­14). Finally, disulfide exchange has been shown to be an effective 
reporter of species populations at thermodynamic equilibrium and can be separated and 
characterized via LC­MS.91  
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 Figure 2­14. Thermodynamic comparison of (Z, Z, hC) with the parent peptide (Z, Z). (a) 
CD spectra before (blue) and after (red) thermal denaturation demonstrates that the 
secondary structure and the reversible folding behavior of (Z, Z) are retained by (Z, Z, hC); 
(b) Thermal denaturation curves for (Z, Z) (green) and (Z, Z, hC) (red) at 30µM. Melting 
temperatures (Tm) are 81.1 °C and 80.7 °C, respectively. 
 
After allowing for dimer equilibration, a mixture containing (F, F, hC), (Z, Z, 
hC), and (F345F, F345F, hC) was oxidized and analyzed using LC­MS (Figure 2­15, 
Table 2­6). Interestingly, out of the six possible dimers only two dimeric species were 
observed: the (F345F, F345F)2 homodimer and the (F, F)–(Z, Z) heterodimer.  
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Figure 2­15. Aromatic stacking interactions facilitate specific self­assembly from complex
mixtures. Shown is an LC trace of a disulfide crosslinking experiment containing the peptides
(F, F, hC), (Z, Z, hC), and (F345F, F345F, hC). Disulfide formation is facilitated in an
oxidized glutathione buffer after allowing the mixed dimers to equilibrate. Out of six possible
species only two were observed in significant quantities: the (F, F)–(Z, Z) heterodimer
(Peak A) and the (F345F, F345F)2 homodimer (Peak B). The third observable peak in the
protein region, indicated with an asterisk (*) is composed of monomer­glutathione adducts,
which are unavoidable minor side products of the crosslinking reaction.
This exclusive self­assembly is presumably driven by complementary π–π
stacking interactions. More specifically, the quadrupole interactions that exist in the (F,
F)–(Z, Z) heterodimer and the dipole­dipole coupling present in the (F345F, F345F)2 
homodimer. This self­sorting behavior afforded by the stacked aromatic pairs is
particularly remarkable given that the three peptides are isosteric and differ only in the
number of hydrogen to fluorine substitutions.
2.3.4  Summary of fluorinated aromatics as self­assembly tools
Herein, we have successfully demonstrated that self­sorting of isosteric peptides
can be achieved from multicomponent mixtures by exploiting the complementary
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interaction mechanisms of stacked pairs of fluorinated aromatic amino acids. Further
­
research will address the generality and scope of this approach in designing self­
assembled materials and inhibitors of protein­protein interactions. Moreover,
fluorinated aromatics seem particular well suited to mediating protein association in the
unique environment of the lipid bilayer, where electrostatic interactions are known to
play key roles protein­protein interactions. Research towards this goal is ongoing.
2.4  Examining CH–π interactions with fluorinated aromatics
It is well known that noncovalent forces govern biomolecular interactions and are
necessary for essentially all cellular processes including cell signaling, growth,
proliferation, communication, and programmed cell death (apoptosis). Interactions such
as hydrogen bonding and salt bridges are commonly observed and well studied examples
of noncovalent interactions present in proteins.83, 89, 92­95 It is becoming increasingly
apparent, however, that weak noncovalent interactions involving aromatic moieties can
contribute significantly to proper folding and function in proteins.31, 35, 37, 58­60, 62 In light
of our findings regarding the ability of fluorination to affect π–π stacking interactions
and afford specific self­assembly behavior in α2D, we have expanded the scope of our
studies by employing fluorinated aromatics to assess the energetic potential of a class of
weak forces known as CH–π interactions.
2.4.1  CH–π interactions in biology
A commonly observed contact in protein structure, the CH–π interaction has
been specifically implicated as a significant contributor to protein­carbohydrate
recognition, with sugar­protein contacts observed in numerous NMR and X­ray crystal
structures. In two noteworthy examples, the sugars that bind with lectin and an E. coli
chemoreceptor protein project their axial C–H bonds into the π clouds of Phe and Trp,
respectively, with contact distances < 3.5 Å (Figure 2­16).96, 97 
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Figure 2­16. Structural evidence supports CH–π interactions as facilitators of protein­
carbohydrate recognition. (a) X­ray structure of β­D­galactose bound to lectin (PDB: 1AX1)
showing its contacts with the F131 π cloud (all contacts measured to be within 3.5 Å); (b) X­
ray structure of β­D­glucose bound to an E. coli galactose chemoreceptor protein (PDB:
2GBP) showing contacts made with the π face of W183 (all contacts measured to be within
3.5 Å).
To fully appreciate the role of CH–π interactions in biomolecular recognition,
however, it is important to assess their energetic potential in an easily characterized
model system. With this goal in mind, we have employed fluorination in α2D as a tool for
examining CH–π interactions. We have generated a series of mutants that contain the
Phe analogue cyclohexylalanine (Cha), which possesses a cyclohexyl group in place of the
phenyl sidechain. The Cha residue should be ideally positioned within α2D to stack
against Phe, Z, or another Cha residue (Figure 2­17). These mutants have been
designated the α2D Cha series, and the same naming system of (X, X) will be employed.
2.4.2  Synthesis and characterization of α2D Cha variants
All α2D variants were synthesized using Fmoc­based SPPS conditions and the
commercially available Fmoc­Gly­Wang resin. Fmoc­removal was achieved by mixing
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with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for five minutes at
room temperature. For each coupling step, five equivalents of the desired amino acid
was activated by O­benzotriazole­N­N­N’­N’­tetramethyl­uronium­hexafluoro­
phosphate (HBTU) and N­methylmorpholine (NMM) for two minutes prior to coupling.
The activated amino acid was then mixed with resin for thirty minutes at room
temperature. For the coupling of all Fmoc­Z and Fmoc­N­cyclohexylalanine (Fmoc­Cha),
three equivalents were activated with HBTU and mixed with resin for 1.5 hrs. Resin
cleavage and sidechain protecting group removal were achieved simultaneously by
mixing resin­bound peptide with a solution of 94% TFA, 2.5% H2O, 2.5% EDT, and 1%
TIS at room temperature for 2 hrs. Ether precipitation followed by centrifugation yielded
the crude product. All peptides were then purified using both prep scale RP­HPLC and
size exclusion chromatography. After purification, all α2D variants were identified and
assessed to be ≥ 95% pure through LC­MS analyses (Table 2­1).
2.4.3  Thermodynamic analyses of α2D Cha variants
In order to examine the inherent energetic potential of CH–π interactions in the
hydrophobic core of α2D, we have generated a series of mutants where Cha and Z replace
Phe at the 10 and/or 29 positions (Figure 2­17). Identical to the nomenclature used
with the fluorinated α2D series, each peptide has been named according to the identity of
the 10 and 29 position residues using the designation (X, X).
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Figure 2­17. A peptide model system for assessing the inherent energetic potential of CH–π
interactions. (a) Primary sequence of α2D, where X denotes the mutation positions; (b)
Cartoon representation of a Cha­containing α2D variant with the aromatic residues shown as
sticks. The residues utilized to examine CH–π are shown with their ESP maps (inset).
The thermodynamic stabilities of all peptide variants were assessed using CD
spectroscopy (Table 2­5). Interestingly, the double mutant (Cha, Cha) failed to
dimerize into the typical α2D structure as indicated by CD characterization (Figure 2­
18). This is thought to be because the larger steric bulk of Cha prohibits packing of all
four Cha sidechains into the α2D core (the Cha sidechain has been calculated to be about
11% larger in volume than Phe). Besides (Cha, Cha), all peptides display CD spectra
60
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with local minima at 220 nm and 208 nm, indicating the expected α­helical secondary 
structure. However, the single mutants (Cha, F) and (F, Cha) demonstrated the 
concentration­depended folding behavior that allows for van’t Hoff analysis, indicating 
that a single Cha mutation at either position is well tolerated by the α2D scaffold.  
 
 
Figure 2­18. Comparison of α2D (Cha, Cha) to other variants. (a) CD spectra at 60 µM for 
the α2D Cha series, with (F, F) as a reference. It is clear that the secondary structure of 
(Cha, Cha) differs from the others and appears to be more random coil than α­helical in 
character. Also note that (Cha, F) and (F, Cha) are the most α­helical; (b) Ellipticity at 222 
nm, normalized to (F, F) and interpreted as % helicity. When (F, F) % helicity is set as 100 
(indicated by the dotted blue line), all single mutants show an increase in helicity, while 
(Cha, Cha) shows only about 40% helicity. These data strongly suggest that (Cha, Cha) 
does not fold under experimentally relevant conditions. 
 
As previously discussed, we hypothesized that a single F to Cha mutation should 
allow for the establishment of CH–π interactions in the core of α2D. Indeed, both (Cha, 
F) and (F, Cha) are significantly more stable than (F, F), by –4.9 and –3.3 kcal mol–1, 
respectively (Table 2­5). These stability increases are consistent with the establishment 
of favorable CH–π interactions between an F­Cha stacked pair. 
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Table 2­5. Summary of thermodynamic parameters for α2D Cha mutants and controls
Peptide Tm (°C) [a]
ΔHf 
(kcal mol–1) [b]
ΔGf 
(kcal mol–1) [c]
ΔΔGf
(kcal mol–1) [d]
(F, F) 28.9 –28.4 ± 2.6 –5.9 ± 0.1 ­­
(Cha, F) 61.0 –58.0 ± 2.7 –10.8 ± 0.2 –4.9
(F, Cha) 53.0 –52.6 ± 4.3 –9.2 ± 0.2 –3.3
(Cha, Cha) N/A [e] N/A [e] N/A [e] N/A [e]
(Z, F) 70.6 –57.0 ± 4.2 –11.8 ± 0.4 –5.9
(Z, Cha) 60.4 –36.2 ± 3.1 –9.2 ± 0.2 –3.3
[a] Peptide concentration of 20 µM; all measurements within ± 1 °C. [b] Calculated by
plotting vs. lnK for different peptide concentrations and using the van’t Hoff
equation [c] Determined at 37 °C, peptide concentration of 20 µM.
[d] ΔΔGf = ΔGf (X, X) – ΔGf (F, F) [e] (Cha, Cha) does not fully fold so thermodynamic
data could not be determined.
In order to further tease out the energetics associated with the CH–π interaction,
we employed a double mutant cycle analysis using Z as a control residue. Because the
electron­poor π face of Z should not interact favorably with the axial hydrogens of Cha,
we prepared the two Z­containing mutants (Z, F) and (Z, Cha). These peptides,
together with (F, F) and (F, Cha), constitute the double mutant cycle (Figure 2­19). A
comparison of (F, F) and (F, Cha) reveals that the F29Cha mutation stabilizes the
folded α2D dimer by –3.3 kcal mol–1, which is presumable the net effect of the favorable
CH–π interactions (ΔGCH–π) and a collection of other factors (ΔGother), including but not
limited to hydrophobicity and sterics. In contrast, introducing the F29Cha mutation to
(Z, F) actually destabilizes the α2D dimer by +2.6 kcal mol–1. This decrease in stability
can be partially accounted for by the elimination of the favorable F­Z quadrupole
interaction (–ΔGquad) in addition to the ΔGother term.
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 Figure 2­19. The double mutant cycle used to evaluate the contribution of the CH–π 
interaction to the stability of α2D. For simplicity, rectangles in the cartoon represent the core 
aromatic stacking residues F (white), Z (black), and Cha (striped). 
   
We have previously estimated the free energy gain associated with the 
98quadrupole interaction of each F­Z stacking pair (ΔGquad) to be –1.0 kcal mol–1.
Elimination of these favorable stacked F­Z pairs in (Z, Cha) should destabilize the 
dimer by +2.0 kcal mol–1. Therefore, we have estimated the ΔGother other term to be +0.6 
kcal mol–1. This positive ΔGother value likely results from the increased steric bulk 
introduced by the F29Cha mutation. With ΔGother estimated, we were able to assess 
ΔGCH–π to be up to –3.9 kcal mol–1, with each F­Cha pair in (F, Cha) contributing as 
much as –2.0 kcal mol–1.98 Because of the predicted orientation of the stacked residues in 
the α2D core (Figure 2­17), we expect that multiple axial hydrogens from each F­Cha 
pair could contribute to the observed net energy gain. If we assume that there are three 
CH–π contacts within each F­Cha pair, each individual CH–π interaction can contribute 
 63
 
  
                 
            
  
               
             
               
                
               
            
        
           
                
           
      
 
         
         
             
               
               
            
              
              
             
                
               
up to –0.7 kcal mol–1 in free energy gain. This estimate is quite consistent with our lab’s
estimate of the ArCH–π interaction between two aromatic moieties packed in the edge­
face geometry.64 
It is important to note that this estimate should be considered the upper limit of
the potential energetic gain afforded by CH–π interactions. Other factors, such as the
elimination of a repulsive interaction between the electron­rich π faces of Phe in (F, F)
when mutating to (Cha, F) or (F, Cha), most likely also contribute to the observed net
stabilization. More optimal steric packing in the core of α2D upon Cha insertion may also
play an important role in the dimer stabilization. Though the interpretation of
thermodynamic data is certainly complicated and necessitates structural
characterization, our data consistently suggests that the stability increases observed in
(Cha, F) and (F, Cha) are at least partially due to the existence of favorable CH–π
contacts. The next section highlights further evidence that supports an electrostatic
contribution to the observed stability increases.
2.4.4  Additional arguments for the existence of CH–π interactions in α2D
The experimentally determined enthalpy values (ΔHf) suggest the energetic
significance of electrostatically favorable CH–π interactions in the core of α2D. When (F,
F) is mutated to (Cha, F) and (F, Cha) the enthalpy of folding becomes significantly
more favorable, by –25 to –30 kcal mol–1, respectively (Table 2­5). This increase in α2D
stability being largely enthalpic in nature is consistent with a favorable electrostatic
interaction from a CH–π contact. These enthalpy values are also similar in magnitude to
those determined for (Z, F) and (F, Z), which are believed to possess favorable
quadrupole interactions known to be electrostatic in nature.87 In contrast, (Z, Cha) has
a much smaller change in ΔHf (–8 kcal mol–1) possibly due to the absence of these
favorable CH–π contacts. Again, the larger size of Z compared to F could also explain the
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enthalpy difference, and it is likely that a combination of different factors contribute to
the net change.
The results obtained with α2D as a model system should be compared to
previously reported model systems investigating a specific class of biologically relevant
CH–π interactions, carbohydrate–π interactions. Using double mutant cycle analysis in a
β­hairpin peptide, Laughrey and coworkers reported association free energies of –0.5
kcal mol–1 to –0.8 kcal mol–1 between a glucose moiety and the aromatic side chains Phe
and Trp, respectively.99 Similarly, Morales and coworkers evaluated carbohydrate­
aromatic stacking in a dangling­ended DNA model system that yielded an association
free energy of –0.4 kcal mol–1 between fucose and benzene.100 Our current estimate is
significantly larger than previously reported data. We hypothesize that this discrepancy
is partially due to different model systems. For example, in both of the aforementioned
reports the interaction pairs are solvent­exposed, so their association propensity could
be dampened by the competition of water. Also, a ligand­binding event introduces an
entropic cost to the binding event. In contrast, our model system sequesters the
interacting pair away from the aqueous environment and preorganizes the sidechains.
Therefore, results from our model system should represent the possible stabilization
afforded by a CH–π interaction. Ultimately structural characterization will be needed to
learn more about the global stability of these variants.
We further hypothesized that the electrostatic component of the CH–π
interactions should enable control of protein dimerization specificities, similar to what
was observed with the fluorinated analogues.73 To test this hypothesis we synthesized
additional H30hC mutants (X, X, hC) and utilized the previously described disulfide
crosslinking assay (Figure 2­13). Because, as previously discussed, it is well known that
disulfide exchange is under thermodynamic control, so after oxidation the cross­linked
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dimers should accurately reflect the equilibrium between the homo­ and heterodimeric
­
α2D species.73 
Figure 2­20. LC traces of (Cha, Cha) before and after oxidation. The black trace shows the
fully reduces monomer prior to glutathione incubation (one clean peak is observed). After 
oxidation, several peaks exist, further evidence that (Cha, Cha) does not fold well.
66
­
  
 
             
                 
           
             
         
        
  
              
            
              
              
                
           
Figure 2­21. LC­MS traces of the disulfide crosslinking experiments between (F, F, hC)
(black trace), (Cha, Cha, hC) (dotted grey trace), and a 1:1 mixture of (F, F, hC) and
(Cha, Cha, hC) (grey trace). Homodimer formation is evident for both peptides, though
dimerization is incomplete for (Cha, Cha, hC). For the 1:1 mixture, the (F, F, hC)–(Cha,
Cha, hC) heterodimer is the major peak. Other observable minor peaks are monomer­
glutathione adducts as well as some residual homodimer.
Both (F, F, hC) and (Cha, Cha, hC) were synthesized and fully reduced with
TCEP prior to analysis. Upon oxidation with excess oxidized glutathione, (F, F, hC)
completely forms the (F, F, hC)2 homodimer after 2 hrs. Not surprisingly, (Cha, Cha,
hC) gave a complex HPLC profile due to its inability to properly fold (Figure 2­20).
When (F, F, hC) and (Cha, Cha, hC) were mixed prior to oxidation, however, a clear
preference for heterodimers was observed upon LC­MS analysis, with almost complete
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(> 80%) heterodimer formation after 2 hrs (Figure 2­21).98 The heterodimer was
identified using ESI­MS (Table 2­6). These data support our argument that the CH–π
interactions exists in our α2D model system while simultaneously emphasizing the use of
weak noncovalent forces in driving the specific association of proteins.
Table 2­6. ESI­MS characterization of α2D cross­linked dimers
Peptide MW Calculated (Da) MW Found (Da)
(F, F)­(F, F) Homodimer
(Z, Z)­(Z, Z) Homodimer
(F345F, F345F)­(F345F, F345F) Homodimer
(F, F)­(Z, Z) Heterodimer
(Cha, Cha)­(Cha, Cha) Homodimer
(F, F)­(Cha, Cha) Heterodimer
8457.6
8818.8
8673,8
8638.6
8481.8
8469.7
8456.1
8820.1
8675.0
8639.0
8482.0
8469.0
2.4.5  Efforts towards structural characterization
The interpretation of thermodynamic data is often complicated. Though our
results support the possibility of an energetically significant, favorable electrostatic
contribution to CH–π interactions to the increased stabilities observed in the (Cha, F)
and (F, Cha) variants, ultimately double mutant cycle analysis is limited to a relative
comparison of the global changes in folding free energy (Figure 2­19). Interpretations
of the thermodynamic data should certainly include contributions from the elimination
of an unfavorable π–π stacking interaction inherent to (F, F), and more optimal steric
packing in the core of (F, Cha) compared with (Z, Cha). The relative contributions of
each of the factors, however, cannot be determined without further structural
characterization.
In order to address these important questions, we are preparing large quantities
of α2D (F, Cha) and (Z, Cha) for crystal screening experiment. Though the small size
and high water solubility of α2D may complicate crystal growth, we hope that, once
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rough growth conditions are obtained, the C2 symmetry of the dimer will make it
predisposed to high quality crystal formation. We hypothesize that, if the size increase
introduced by the F10Z mutation predominantly accounts for the difference in folding
free energy, there must be a structural rearrangement in the core of the folded dimer to
accommodate the steric bulk. Efforts towards addressing this key question are currently
underway.
2.4.6  Summary of CH–π interactions
In summary, we have utilized pentafluorophenylalanine (Z) to analyze the
energetics of F­Cha stacking in the core of the model peptide α2D. The data have revealed
a strong pairwise interaction between the F and Cha sidechains, which yields –2.0 kcal
mol–1 in folding free energy.98 If we assume that, for each F­Cha pair, three axial
hydrogens make favorable contacts with the π cloud of F, each CH–π interaction could
contribute up to –0.7 kcal mol–1 in folding free energy (Figure 2­19). It is important to
note that this estimate represents the greatest potential strength of a CH–π interaction
due to the solvent­excluded environment and the contributions of other factors such as
sterics and the elimination of F­F repulsion. Further structural characterization is
needed to elucidate the relative contributions from each of these factors to the F­Cha
interaction. Nevertheless, we have demonstrated that the F­Cha stacked pair can
effectively facilitate heterodimer formation between (F, F, hC) and (Cha, Cha, hC)
(Figure 2­21). To the best of our knowledge this study represents the first assessment of
CH–π interactions inside a protein core, where all solvent effects should be minimized.
Further insight into the inherent energetics of weak noncovalent interactions should
advance our understanding of molecular recognition in chemistry and biology.
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2.5  Beyond π­π stacking – examining the energetics of halogen bonding
�
Our studies up to this point have focused on elucidating the influence of
fluorination on the electronic properties of the aromatic moiety and these properties’
subsequent importance in π–π stacking and CH–π interactions. The unique properties of
fluorinated aromatics should also allow them to engage in a type of noncovalent
interaction known as halogen bonding.
Figure 2­22. Introduction to halogen bonding. (a) ESP maps for CF4, CF3Cl, CF3Br, and
CF3I showcase the polarizing effect along the sigma axis of the C–X bond. This effect
increases with the polarizability of the halogen and is the origin of halogen bonding; (b)
Schematic of halogen bonding, showing the possible donors and acceptors. Image
reproduced from Reference 101.
Halogen bonding is defined as an electrostatic interaction between a classical
hydrogen bond acceptor (an electronegative O, N, or S atom) or other electron rich
moieties (such as a π cloud) and an electropositive, polarizable halogen atom (Cl, Br, I)
(Figure 2­22). Typically, the strength of the donor is I > Br > Cl. Although this
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noncovalent interaction has been recognized for over 100 years, it has only gained
­
widespread popularity in the last 10­15 years. Studies in crystal formation have shown
that halogen bonding and hydrogen bonding share similar geometric requirements and
also comparable strengths.101 Furthermore, neighboring electron withdrawing groups,
such as fluorine, can enhance the positive charge on the halogen atom, strengthening the
interaction. Although there is much evidence in to support the stabilizing effects of
halogen bonding in organic solvents101, few studies have examined its existence and
energetic scale in the context of water soluble proteins. Notable applications of halogen
bonding in chemical biology will be discussed in the following section.
2.5.1  Halogen bonding in protein design
Due to its stringent geometric requirements, studies of halogen bonding have
largely focused on its ability to direct crystal formation and self­assembly of materials.101 
Unsurprisingly, one of the earliest applications of halogen bonding in chemical biology
involved its use in directing macromolecular conformation. In 2007, Ho and co­workers
demonstrated the ability of a brominated uracil to effectively compete with a hydrogen
bond in a DNA junction.102 
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Figure 2­23. Applications of halogen bonding in chemical biology. (a) DNA junction
showing the structural rearrangement induced by halogen bond formation. Halogen bonding
was shown to be able to effectively compete with hydrogen bonding. Image reproduced from
Reference 102.; (b) Active site of hCatL illustrating the binding mode of the inhibitors. The
substituted halogen (I > Br > Cl) interacts favorably with the carbonyl oxygen of Gly61.
Image reproduced from Reference 103.
Additionally, the energetic potential of halogen bonding in protein­ligand
interactions has been examined computationally and experimentally.101, 103 Diederich and
co­workers have examined the strength of halogen bonding interactions in the human
proteinase Cathepsin L (hCatL) by systematically replacing the halogen in position X and
measuring its effect on the ligand binding affinity (Figure 2­23).103 In order to
investigate the influence of halogen bonds on protein stability, we have generated a
library of a naturally occurring peptide, the PinWW domain.
2.5.2  The model peptide PinWW
The PinWW domain, part of a proline cis/trans isomerase involved in cell cycle
regulation, was chosen a model system due to its stability and easily characterized 2­
state folding mechanism.104, 105 An additional advantage is its high tolerance to point
mutations. This 34­residue peptide assumes a predominantly β­sheet secondary
structure with two loop regions (Figure 2­24a). It was concluded that residues F25 and
72
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N30, located in one of these partially exposed flexible loop regions, would be ideal 
positions for introducing point mutations. Residue N30 was mutated to glutamic acid 
(Glu) and norvaline (Nva) in order to investigate the ability to participate in a halogen 
bond with the F25 position (Figure 2­24b). 
 
 
Figure 2­24. PinWW as a model peptide for investigating halogen bonding in soluble 
peptides. (a) PinWW primary sequence showing the mutation sites for donor (F25X) and 
acceptor (E, Nva); (b) PinWW structure (PDB 1F8A) of the F25Y N30E variant, showing the 
close proximity (within 3 Å) and geometry necessary to establish hydrogen and halogen 
bonds. The donors utilized in this study are shown on the right (inset). 
 
Similar to the naming system used with α2D, the PinWW series have been 
designated according to the residues in positions 25 and 30. For example, the PinWW 
double mutant F25 N30E will be known as (F, E). We hypothesized that the Phe 
analogue 4­iodo­2,3,5,6­tetrafluorophenylalanine (ZpI)  
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2.5.3  Peptide synthesis and characterization
�
All PinWW variants were synthesized using Fmoc­based SPPS conditions and the
commercially available Fmoc­Gly­Wang resin. Fmoc­removal was achieved by mixing
with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for five minutes at
room temperature. For each coupling step, five equivalents of the desired amino acid
was activated by O­benzotriazole­N­N­N’­N’­tetramethyl­uronium­hexafluoro­
phosphate (HBTU) and N­methylmorpholine (NMM) for two minutes prior to coupling.
The activated amino acid was then mixed with resin for thirty minutes at room
temperature. For the coupling of all unnatural amino acids, three equivalents were
activated with HBTU and mixed with resin for 1.5 hrs. The unnatural amino acid 4­iodo­
2,3,5,6­tetrafluorophenylalanine (ZpI) was prepared by Dr. Luoheng Qin according to
published protocol.8 Resin cleavage and sidechain protecting group removal were
achieved simultaneously by mixing resin­bound peptide with Reagent K for 1 hr. Ether
precipitation followed by centrifugation yielded the crude products. All peptides were
then purified using both prep scale RP­HPLC and size exclusion chromatography. After
purification, all PinWW variants were identified and assessed to be ≥ 95% pure through
LC­MS analyses (Table 2­7).
Table 2­7. ESI­MS characterization of PinWW variants
Peptide MW Calculated (Da) MW Found (Da)
(F, E)
(Y, E)
(F4I, E)
(Z, E)
(Zp, E)
(ZpI, E)
(Z, Nva)
(ZpI, Nva)
4038.5
4054.5
4163.9
4128.4
4110.5
4236.4
4098.4
4206.4
4039.0
4055.5
4166.0
4130.0
4110.0
4235.0
4096.0
4205.0
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2.5.4  Thermodynamic analysis of halogen bonding in PinWW
The secondary structures and stabilities of all α2D and PinWW variants were
examined using thermal and chemical denaturation experiments and were monitored by
CD spectroscopy (Table 2­8).
Table 2­8. Thermodynamic parameters for selected and PinWW (X, X) mutants
Peptide Tm (°C) [a] Cm (M) [b]
ΔGf 
(kcal mol–1) [c]
ΔΔGf 
(kcal mol–1) [d]
PinWW (F, E) 46.1 2.14 ± 0.03 –2.16 ± 0.04 ­­
PinWW (Y, E) 52.3 3.34 ± 0.02 –2.91 ± 0.06 –0.75
PinWW (F4I, E) 51.5 3.32 ± 0.02 –2.72 ± 0.07 –0.56
PinWW (Z, E) 52.8 4.38 ± 0.03 –3.25 ± 0.08 –1.09
PinWW (Zp, E) 55.1 4.15 ± 0.03 –3.37 ± 0.04 –1.21
PinWW (ZpI, E) 52.2 3.90 ± 0.02 –3.23 ± 0.05 –1.07
PinWW (Z, Nva) 57.9 4.45 ± 0.04 –3.60 ± 0.06 –1.44
PinWW (ZpI, Nva) 54.0 4.17 ± 0.02 –3.42 ± 0.10 –1.26
[a] Peptide concentration of 40 µM; all measurements within ± 1 °C. [b] Determined by
fitting the curve generated from GdmCl denaturation experiments. [c] Determined at 37
°C, peptide concentration of 20 µM. [d] ΔΔGf = ΔGf Mutant – ΔGf WT 
Folding free energies for the PinWW variants were calculated from the
experimentally determined Cm values. Once all folding free energies were calculated,
double mutant cycles were employed to compare the relative strengths of hydrogen
bonding and halogen bonding in PinWW. We first examined the relative stabilities of (F,
E), (Y, E), (Z, E), and (ZpI, E) (Figure 2­25a). The addition of a hydrogen bond
between Tyr and Glu in (Y, E) stabilized the folded peptide by –0.75 kcal mol–1. In
contrast, a negligible change in folding free energy was observed when Z was mutated to
ZpI. These data suggest that halogen bonding in PinWW does not exists or is too weak to
detect with our current model system.
75
­
 Figure 2­25. Double mutant cycle analysis to examine the significance of halogen bonding 
compared to hydrogen bonding in PinWW. (a) A comparison between hydrogen bonding 
and halogen bonding in PinWW. No energetically significant halogen bond exists; (b) A 
comparison between an iodine substitution in the presence vs. the absence of the halogen 
bond donor Glu (E). Even if the interaction exists, it is extremely weak. 
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Next, we synthesized a pair of mutants containing norvaline (Nva), an isostere to
­
Glu that cannot engage in hydrogen or halogen bonding (Figure 2­25b). Double mutant
cycle analysis of these variants suggests the possible existence of a favorable interaction
between ZpI and E in comparison to Z, though it is quite weak and not conclusive. These
results are not too surprising when one considers the influence of local environment and
geometry on the strength of non­covalent interactions such as hydrogen bonds and
halogen bonds.
2.5.5 	 Summary of halogen bonding
We have expanded the scope of fluorinated aromatic amino acids by utilizing
them to investigate the significance of halogen bonding in the loop region of a small
peptide, the PinWW domain. Our results illustrate that only a very weak interaction
exists, if at all. Though inconclusive, these studies demonstrate that the strength of a
halogen bond, much like other non­covalent interactions, may depend on a number of
possible factors, such as solvent exposure, conformational flexibility, and distance.
2.6 	 Beyond π­π stacking – steric effects of point mutations on peptide
stability
Our studies up to this point have focused on elucidating the impact of
fluorination on the electronic properties of the aromatic moiety and these properties’
subsequent importance in π–π stacking, CH–π interactions, and halogen bonding.
Although we have established that fluorination is often sterically conservative, even a
subtle change in sterics could affect the overall stability of a protein if the mutation
cannot be well tolerated by the protein fold. One must therefore be cautious when
interpreting thermodynamic data in terms of sterics without more rigorous analysis. A
more general understanding of the introduction of steric bulk into model peptides,
specifically how these peptides can tolerate this bulk, will be valuable to the fields of
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protein design and drug development. We have hypothesized that the inherent plasticity
­
of proteins should allow for the tolerance of increased bulk only to a certain point.
Towards this end, we have chosen to investigate the influence of residue size on the
stability of two soluble peptides, α2D and PinWW.
2.6.1  The model peptide PinWW
As previously discussed, PinWW is a convenient model system due to its stability
and easily characterized 2­state folding mechanism.104, 105 Importantly, PinWW is a
naturally­0curring peptide, which will be interesting to compare to the de novo designed
peptide α2D. Upon closer examination of the structure it was concluded that residues
F25 and N30, which were used to study halogen bonding in PinWW, are also ideal
positions for investigating steric effects. The (X, E) series of mutants were expanded and
utilized for our studies (Figure 2­26).
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Figure 2­26. PinWW as a model peptide for investigating the effects of sterics on protein
stability. (a) The primary sequences of the (F, E) variant and the mutant (X, E) are shown
for clarity; (b) Cartoon (PDB: 1F8A) showing the location of Phe25 and Glu30 in the flexible
loop region of PinWW (Left); Space­filling model illustrates that Phe25 is confined in a
pocket even though it is partially exposed (right).
2.6.2  Peptide synthesis and characterization
All α2D and PinWW variants were synthesized using Fmoc­based SPPS
conditions and the commercially available Fmoc­Gly­Wang resin. Fmoc­removal was
achieved by mixing with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for
five minutes at room temperature. For each coupling step, five equivalents of the desired
amino acid was activated by O­benzotriazole­N­N­N’­N’­tetramethyl­uronium­
hexafluoro­phosphate (HBTU) and N­methylmorpholine (NMM) for two minutes prior
to coupling. The activated amino acid was then mixed with resin for thirty minutes at
room temperature. For the coupling of all unnatural amino acids, three equivalents were
activated with HBTU and mixed with resin for 1.5 hrs. Resin cleavage and sidechain
protecting group removal were achieved simultaneously by mixing resin­bound peptide
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with a solution of 94% TFA, 2.5% H2o, 2.5% EDT, 1% TIS (used for α2D series) or
Reagent K (PinWW series) at room temperature for 1.5 hrs or 1 hr, respectively. Ether
precipitation followed by centrifugation yielded the crude products. All peptides were
then purified using both prep scale RP­HPLC and size exclusion chromatography. After
purification, all PinWW variants were identified and assessed to be ≥ 95% pure through
LC­MS analyses (Table 2­7).
2.6.3 	 Thermodynamic analyses and comparison of PinWW and α2D
variants
The secondary structures and stabilities of all α2D and PinWW variants were
examined using thermal and chemical denaturation experiments and were monitored by
CD spectroscopy (Table 2­9).
Table 2­9. Thermodynamic parameters for selected α2D and PinWW (X, X) mutants
Peptide Tm (°C) [a] Cm (M) [b]
ΔGf 
(kcal mol–1) [c]
ΔΔGf 
(kcal mol–1) [d]
α2D (F, F) 28.9 N/A –5.9 ± 0.1 ­­
α2D (F4I, F4I) 65.4 N/A –11.2 ± 0.2 –5.3
α2D (Zp, Zp) 52.2 N/A –8.7 ± 0.1 –2.8
α2D (ZpI, ZpI) 75.8 N/A –12.6 ± 0.2 –6.7
α2D (Z, Z) 78.3 N/A –12.6 ± 0.4 –6.7
PinWW (F, E) 46.1 2.14 ± 0.03 –2.16 ± 0.04 ­­
PinWW (F4I, E) 51.5 3.32 ± 0.02 –2.72 ± 0.07 –0.56
PinWW (Zp, E) 55.1 4.15 ± 0.03 –3.37 ± 0.04 –1.21
PinWW (ZpI, E) 52.2 3.90 ± 0.02 –3.23 ± 0.05 –1.07
PinWW (Z, E) 52.8 4.38 ± 0.03 –3.25± 0.08 –1.09
[a] Peptide concentration of 20 µM (α2D) and 40 µM (PinWW), respectively; all
measurements within ± 1 °C. [b] Determined by fitting the curve generated from
GdmCl denaturation experiments (not run for α2D variants). [c] Determined at 37 °C,
peptide concentration of 20 µM. [d] ΔΔGf = ΔGf Mutant – ΔGf WT 
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For the α2D series, folding free energies (ΔGf) were determined according to the
previously describe protocol (Experimental Procedures). Folding free energies for
the PinWW variants were calculated from the experimentally determined Cm values.
Once all folding free energies were calculated, double mutant cycles were employed to
examine the effects of sidechain size on peptide stability (Figure 2­27). The increased
stability afforded by sidechain mutation in α2D is much more pronounced than that of
PinWW. This result is somewhat expected given the location of the residues in α2D
(completely sequestered) and the previously discussed favorable π–π stacking
interactions. Also, it is important to note that each α2D contains two mutated Phe
analogues while PinWW contains only one mutated aromatic sidechains.
81
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 Figure 2­27. Double mutant cycle analysis to evaluate the influence of steric bulk on the 
stability of two model peptides. (a) Analysis of α2D variants shows a decrease in stability 
gain upon the addition of iodine to F vs. Zp, hinting at a limit in the protein tolerance for 
steric bulk; (b) Analysis of PinWW mutants reveals a similar trend to α2D despite the 
different local environments of the peptides. These data point to a general effect of point 
mutations on global protein stability. 
 
Upon mutation of the native Phe, both para­iodination and tetrafluorination 
stabilize the folded states of α2D and PinWW, though to different extents (–5.3 kcal mol–1 
and –0.6 kcal mol–1, respectively for para­iodination and –2.8 kcal mol–1 and –1.2 kcal 
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mol–1, respectively for tetrafluorination). Based on these data, one would predict that
para­iodination of 2,3,5,6­tetrafluorophenylalanine would yield a similar stabilizing
effect in each model system, assuming the increased steric bulk is well tolerated.
Interestingly, for PinWW this mutation is actually slightly destabilizing (+0.1 kcal mol–1).
In both model systems, the effect of para­iodination is less stabilizing when substituting
iodine onto the Zp sidechain compared with F. Furthermore, for both PinWW and α2D
the FXZ mutants display identical folding free energies to the FXZpI mutants, despite the
significant increase in hydrophobicity afforded by the ZpI sidechain. While the exact
origin of this nonadditivity is unknown, it is presumably due the model peptides being
unable to tolerate the combined steric bulk associated with the FXZpI mutation, despite
easily accommodating the individual mutations in FXF4I and FXZp. Though the
thermodynamic data is compelling, further structural characterization is required to
determine the importance of protein plasticity in the global consequences of
mutagenesis. Research in this direction is currently underway.
2.6.4  Summary of steric effects
In conclusion, we have extended our application of fluorinated aromatic amino
acids to the investigation of steric effects in two distinct model proteins. Thermodynamic
analysis reveals a “stabilization plateau” where increased steric bulk is no longer
tolerated despite a larger hydrophobic surface area (Figure 2­27). The fact that these
results are consistent for two distinct model peptides lends credibility to the argument
that the observed toleration limits are general effects of site­specific mutagenesis.
Further studies are underway to elucidate how these mutations affect protein structure
at the atomic level.
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2.7  Beyond fluorinated phenylalanine derivatives
�
As a chemical biology tool, fluorination of aromatic amino acids is certainly not
limited to phenylalanine. For example, as previously discussed, fluorinated Trp
analogues have been utilized to probe the energetic significance of cation–π interactions
as well as to monitor protein insertion into the cell membrane via 19F­NMR.7 Perhaps the
most intriguing applications, however, involve the fluorination of tyrosine (Tyr). In
addition to the enhanced hydrophobicity and electronic effects, fluorination of Tyr also
perturbs the residue’s pH response. The physical consequences and applications of Tyr
fluorination will be discussed in greater detail in the following sections.
2.7.1  Tetrafluorotyrosine (ZpOH) as a pH switch
The ability to impart pH­dependent structure and function into a target protein
represents a key advantage of Tyr fluorination. In a native Tyr residue the phenolic
proton has a pKa of about 10.0, but when fully fluorinated its acidity is drastically
increased to a pKa range of 5.5­6.0.106 As expected, partial fluorination results in a
decrease in the pKa to a lesser extent. Therefore, while Tyr is fully protonated at
physiological pH, tetrafluorotyrosine (ZpOH) displays pH­sensitivity in the
physiologically relevant range of 6.0­6.5 and exists in the fully deprotonated, anionic
form at pH 7.0. These fluorinated Tyr analogues have been utilized to elucidate the
mechanisms of a variety of enzymes.14, 106, 107 More recently, our group has developed an
efficient synthesis for the preparation of Fmoc­ZpOH in gram quantities and has
incorporated it into the membrane­lytic peptide magainin 2 via standard SPPS
conditions. The ZpOH­containing magainin variant does not lyse model membranes at
pH 7.0, but its activity is rescued at mildly acidic pH, presumably due to the protonation
of ZpOH.108 Inspired by these results, we have further examined the ability of ZpOH to
serve as a pH sensitive moiety in the context of the antimicrobial peptide gramicidin A
(gA). These studies will be discussed in greater detail below.
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2.7.2  Engineering pH­dependent activity into an antimicrobial peptide
The rapid emergence of drug­resistant pathogens poses a significant threat to the
healthcare industry. Not surprisingly, there is a high demand for antibiotics that possess
novel mechanisms of action (MOA).109 The MOA of the monovalent ion channel
gramicidin A (gA) fits this profile nicely: driven by the hydrophobic effect, it inserts into
the cell membrane and facilitates diffusion of H+, Na+, and K+ down the concentration
gradient (Figure 2­28). Nevertheless, its medical application has been limited to a
topical agent due to its poor solubility and selectivity. We hypothesized that a variant of
gA that contains ZpOH would not show activity due to the anionic charge on ZpOH as
physiological pH; its activity, however, could be rescued by a decrease in pH to afford a
neutral, hydrophobic peptide.
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Figure 2­28. Using ZpOH to engineer pH­dependent activity into the antimicrobial peptide
gramicidin A (gA). The pH­dependent channel activity, correlated to K+ leakage from human
erythrocytes (hRBC), makes sense given the sidechain pKa of ZpOH.
Towards this end, we have engineered gA to display pH­dependent channel
activity by incorporating ZpOH. Preliminary studies have confirmed that the channel
activity towards hRBCs, eliminated at physiological pH, can be rescued upon
acidification. Efforts to further characterize these mutants are currently underway.
2.8  Conclusion
In summary, through the systematic thermodynamic characterization of the
model peptides α2D and PinWW, we have illustrated the utility of fluorinated aromatic
amino acids as tools for both stabilizing protein structure and as facilitators of highly
specific protein self­assembly. Our work with the α2D (F, X) and (X, X) series has led to
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a better understanding of the physical properties, such as dipole­dipole and dipole­

induced dipole coupling, that contribute to favorable π–π stacking interactions. We have
determined that, due to the favorable combination of hydrophobicity and dipole
moment, Zo is the best stacking partner for native Phe. Furthermore, we have
demonstrated the ability of aromatic residues, through complementary mechanism of
interaction, to mediate specific self­assembly from multicomponent mixtures. Finally,
we have showcased the potential scope of fluorinated aromatic amino acids by
incorporating pH­dependent activity into α2D and gA via ZpOH sidechain. With our
newly improved understanding of the fundamental energetics of aromatic interactions
we are well positioned to begin examining their potential use as mediators of
transmembrane protein association, specifically TMHs.
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Experimental Procedures
I.  General methods
All chemicals were obtained from Thermo Fisher Scientific (Waltham, MA) or
Sigma­Aldrich (St. Louis, MO) unless otherwise noted. Fmoc­Gly­Wang resin was
purchased from Novabiochem (San Diego, CA). All Fmoc­protected natural α­amino
acids, HBTU, and piperidine were purchased from Advanced Chemtech (Louisville, KY).
N­methylmorpholine (NMM) was purchased from TCI AMERICA (Portland, OR). Fmoc­
N­pentafluorophenylalanine (Fmoc­Z) was purchased from PepTech Corporation
(Burlington, MA). All other commercially available Fmoc­protected fluorinated Phe
derivatives were purchased from Chem­Impex International, Inc. (Wood Dale, IL).
Fmoc­N­cyclohexylalanine (Fmoc­Cha) and Fmoc­N­homocysteine (Fmoc­hCys) were
also purchased from Chem­Impex International, Inc. Fmoc­N­tetrafluorotyrosine
(Fmoc­ZpOH) and Fmoc­N­2,3,5,6­tetrafluoro­4­iodophenylalanine (ZpI) were
synthesized according to previously reported protocol.8, 108 Peptide synthesis was carried
out on a Tribute® peptide synthesizer (Protein Technologies, Tucson, AZ). All crude
peptides were purified by RP­HPLC using a Jupiter C18 300 Å (250 x 20.00 mm, 10 µm)
prep column (Phenomenex, Inc., Torrance, CA) on a Waters PrepLC system (Waters
Corporation, Milford, MA). Size exclusion chromatography was conducted with a HiLoad
SuperdexTM 30 column on the ÄKTA FPLC system (GE Healthcare, Piscataway, NJ). All
ESI­MS data were generated by the Boston College Mass Spectrometry Facility (NSF
grant no. DBI­0619576). Protein concentration was determined spectrophotometrically
by measure Trp absorbance at 280 nm (ε = 5690 M­1 cm­1 per Trp residue) using either a
Lambda 25 UV­Vis spectrometer (PerkinElmer, Waltham, MA) or a Nanodrop 2000c
spectrophotometer (Thermo Fisher Scientific). Circular dichroism (CD) experiments
were conducted using an Aviv Model 420 spectrometer (Aviv Biomedical, Inc.,
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Lakewood, NJ) and a quartz curvet with a path length of 2 mm. All disulfide crosslinking
experiments were analyzed using a Jupiter C18 300 Å (150 x 2.00 mm, 5 µm) column
(Phenomenex, Inc., Torrance, CA) on an e2695 analytical LC system (Waters
Corporation, Milford, MA). All physical properties of the Phe sidechain analogues were
calculated using the PM3 semi­empirical model in Spartan 2010 (Wavefunction, Inc.).
II.  Synthesis of Fmoc­N­tetrafluorophenylalanine (Fmoc­Zx) series
Utilizing the Schöllkopf chiral auxiliary70, we have developed a route to the Fmoc­
Zx series that employs milder hydrolysis conditions than our previously reported scheme
using Seebach’s auxiliary. We have successfully synthesized Fmoc­Zm in high yield (44%
overall from 1) and high enantiopurity through this method (Scheme 2­2).
Furthermore, this scheme should allow for access to the entire library of fluorinated Phe
analogues through their corresponding benzyl alcohol or benzyl bromide precursors.
Experimental details and characterization data for each step in the synthesis are
provided below.
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 Scheme 2­2. Synthesis of Fmoc­Zm 7 via the Schöllkopf chiral auxiliary 4. Conditions: (a) 
PBr3, pyridine, DMSO; (b) EtO3BF4, DCM, 25 °C, 72 hrs; (c) 1) nBuLi, THF, –78 °C, 30 
mins; 2) 2,3,4,6­tetrafluorobenzyl bromide, –78 °C, 2 hrs; (d) 2 N HCl, THF, 0 °C to 25 °C, 
2hrs; (e) 1) 1 N NaOH, EtOH, 50 °C, 2 hrs; 2) 10% Na2Co3, CH3CN, Fmoc­Osu, 0 °C to 25 °C, 
45 mins. 
 
2,3,4,6­tetrafluorobenzyl bromide (2) 
In a round bottom flask 2,3,4,6­tetrafluorobenzyl alcohol 1 (2 g, x 11.1 mmols) 
was dissolved in DMSO (0.16 mL, 2.25 mmols) and pyridine (0.27 mL, 3.35 mmols), and 
placed in a room temperature water bath. To this solution was added phosphorous 
tribromide (0.70 mL, 7.38 mmols) dropwise at room temperature, and the solution was 
allowed to stir for 30 mins. The reaction was quenched with H2O and the organic layer 
separated. The organic layer was then extracted twice with DCM. The combined organic 
layers were dried with sodium sulfate. The solvent was then evaporated under reduced 
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pressure, yielding 2 as a brown oil (79%). No further purification step was necessary. 1H­
NMR (400 MHz, CDCl3) δ 4.40 (s, 2H), 6.75 (m, 1H); 13C­NMR (125 MHz, CDCl3) δ
[156.8, 154.7], [151.5, 149.5], [150.3, 148.4], [138.4, 136.4], 112.2, 101.2, 16.8; HRMS
(ESI­) for C7H3BrF4 calculated 243.93340 found 242.95660. Bracketed 13C chemical
shifts represent single carbons as two peaks due to C­F splitting.
(2R,5S)­3,6­diethoxy­2­isopropyl­5­(2,3,4,5­tetrafluorobenzyl)­2,5­
dihydropyrazine (5)
In a flame­dried round bottom flask, 4 (1 g, 4.71 mmols) was dissolved in dry
THF (45 mL) and cooled to –78 °C in a dry ice/acetone bath. Once cooled, nBuLi (2.3
mL, 2.5 M in hexanes) was added dropwise and allowed to mix for 30 mins at –78 °C. To
this solution was added 2 (1.36 g, 5.60 mmols) and stirred for 2 hrs at –78 °C. The
reaction was then quenched with saturated ammonium chloride and the organic layer
separated. The aqueous layer was extracted three times with DCM, and the combined
organic layers were washed three times with brine and dried over sodium sulfate. The
crude product was purified via silica gel chromatography run with 4:1 hexanes: ethyl
acetate, yielding 5 as an off­white solid (96%, ≥20:1 dr confirmed by 1H­NMR). 1H­NMR
(500 MHz, CDCl3) δ 0.65 (d, 3H), 0.99 (d, 3H), 1.23 (t, 3H), 1.29 (t, 3H), 2.23 (m, 1H),
2.89 (d, 1H), 3.22 (d, 1H), 3.77 (t, 1H), 3.99 (q, 3H), 4.11 (m, 1H), 4.19 (q, 3H), 6.76 (m,
1H); 13C­NMR (125 MHz, CDCl3) δ 163.6, 162.0, [156.7, 154.7], [151.2, 149.3], [150.1,
148.2], [138.0, 136.1], 112.1, 99.9, 60.9, 60.7, 60.5, 54.8, 31.6, 28.0, 18.9, 16.5, 14.3, 14.2;
HRMS (ESI+) for C18H22F4N2O2 calculated 375.16957 found 375.16929. Bracketed 13C 
chemical shifts represent single carbons as two peaks due to C­F splitting. The correct
diastereomer was confirmed through a 2D 1H­1H NOESY experiment (Figure 2­8).
2,3,4,6­tetrafluorophenylalanine ethyl ester (6)
In a round bottom flask 5 (994 mg, 2.52 mmols) was dissolved in THF (44 mL) at
room temperature and cooled to 0 °C. Next, 2 N HCl (37 mL) was slowly added to the
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solution. The reaction was then mixed for 10 mins at 0 °C and warmed to room
­
temperature over 2 hrs. Excess ice was added, and the pH was tuned to 7.0­8.0 with
aqueous ammonia. The organic layer was separated, and the aqueous layer was extracted
three times with DCM. The combined organic layers were washed twice with brine and
dried was sodium sulfate. The crude product was purified via silica gel chromatography
(column packed and loaded with 100% hexanes, run with 100% ethyl acetate), yielding 6
as an off­white solid (82%). 1H­NMR (500 MHz, CDCl3) δ 1.24 (t, 3H), 2.91 (dd, 1H),
3.08 (dd, 1H), 3.64 (t, 1H), 4.17 (q, 2H), 6.75 (m, 1H); 13C­NMR (125 MHz, CDCl3) δ
174.7, [156.8, 154.8], [151.4, 149.4], [150.6, 148.6], [138.2, 136.3], 111.3, 100.6, 61.4, 54.1,
28.1, 14.1; HRMS (ESI+) for C11H11F4NO2 calculated 266.08042 found 266. 08079.
Bracketed 13C chemical shifts represent single carbons as two peaks due to C­F splitting.
The enantiopurity of the product x was confirmed using the Marfey’s test protocol.110 
Fluorenylmethyloxycarbonyl­N­2,3,4,6­tetrafluorophenylalanine (7)
In a round bottom flask 6 (432 mg, 1.63 mmols) was dissolved in ethanol (8.15
mL) and mixed with 1 M NaOH (5.42 mL) for 2 hrs at 50 °C. The reaction was quenched
with ice, and the pH was adjusted to 7.0 with 2 N HCl. The solvent was evaporated and
the solid directly redissolved in 9% sodium carbonate (6.5 mL) and cooled to 0 °C. Next,
Fmoc­Osu (549 mg, 1.68 mmols) was dissolved in acetonitrile (5.7 mL) and added to the
sodium carbonate solution. The reaction was stirred vigorously for 45 mins while
warming up to room temperature. After 45 mins, glycine was added to react with any
excess Fmoc­Osu, and the reaction was stirred for an additional 15 mins at room
temperature. The reaction was diluted with water, and the aqueous phase was tuned to
pH 2.0 with concentrated HCl. The organic layer was separated, and the aqueous phase
was extracted six times with ethyl acetate. The organic layer was then washed twice with
brine and twice with water. The crude product was purified via silica gel
chromatography run with 2:1 hexanes: ethyl acetate (to elute unreacted Fmoc­Osu)
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followed by 2:1 hexanes: ethyl acetate containing 2% acetic acid. The target molecule,
Fmoc­N­2,3,4,6,­tetrafluorophenylalanine 7, was obtained as a fluffy white solid (71%
over 2 steps). The overall yield was 41% from 1 (benzyl alcohol). 1H­NMR (500 MHz,
CD3OD) δ 3.17 (dd, 1H), 3.31 (dd, 1H), 4.18 (t, 1H), 4.29 (t, 2H), 4.46 (dd, 1H), 7.05 (m,
1H), 7.34 (m, 2H), 7.42 (m, 2H), 7.64 (m, 2H), 7.82 (m, 1H); 13C­NMR (125 MHz,
CD3OD) δ 172.5, [157.1, 155.2], 157.0, [151.2, 149.2], [150.6, 148.6], 143.8, 143.7, 141.2,
141.1, [137.9, 135.9], 127.4, 126.7, 124.8, 124.7, 119.5, 111.2, 100.3, 66.7, 56.1, 53.7, 53.1,
46.9, 24.6, 19.3; HRMS (ESI+) for C24H17F4NO4 calculated 459.10940 found 477.14295
[M + NH4+]+. Bracketed 13C chemical shifts represent single carbons as two peaks due to
C­F splitting.
III.  Peptide synthesis, purification, and characterization
All peptides were synthesized via automated solid phase peptide synthesis
(SPPS) on a Tribute® peptide synthesizer (Protein Technologies, Tucson, AZ) using
standard Fmoc/tBu chemistry (Table 2­10). Syntheses were performed using 0.02­0.1
mmol Fmoc­Gly­Wang resin as the solid support (depending on the scale). All peptides
were synthesized with an N­terminal amine and a C­terminal carboxylic acid. Removal of
the Fmoc protecting group was accomplished by treating resin­bound peptide with a
solution of 20% v/v piperidine in DMF twice for 5 mins at room temperature under N2 
protection. For standard coupling steps, 5 eq. of Fmoc­protected amino acid were mixed
with 5 eq. of HBTU and subsequently dissolved in a solution of 0.4 M N­
methylmorpholine (NMM) in DMF. After 2 mins the activated amino acid solution was
delivered to the resin under N2 protection and mixed for 30 mins at room temperature.
For the coupling of unnatural residues, 3 eq. of the amino acid were manually activated
and mixed with resin under N2 protection for 1 hr at room temperature (HBTU­mediated
activation conditions are identical to standard coupling). If deemed necessary, the
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unnatural amino acid coupling efficiency was monitored by the Ninhydrin test. After
­
coupling the unnatural amino acids, unreacted free amines were capped by treating resin
with 10% v/v acetic anhydride in DMF twice for 30 mins at room temperature under N2 
protection. Upon completion of SPPS, peptide removal from resin and sidechain
deprotection were simultaneously accomplished by treating resin­bound peptide with
the following solutions for 2 hrs at room temperature: 94% TFA, 2.5% H2o, 2.5% EDT,
1% TIS (used for α2D series) or 82.5% TFA, 5% H2O, 5% phenol, 5% thioanisole, 2.5%
EDT (Reagent K, used for PinWW series). Ether precipitation followed by centrifugation
yielded the crude products as off­white solids.
Table 2­10. Primary sequences of α2D and PinWW variants
Peptide (Variant) Primary Sequence
α2D (F, F) 
α2D (X, F) 
α2D (F, X) 
α2D (X, X) 
α2D (X, X, hC) 
GEVEELEKKFKELWKGPRRGEIEELHKKFHELIKG
GEVEELEKKXKELWKGPRRGEIEELHKKFHELIKG
GEVEELEKKFKELWKGPRRGEIEELHKKXHELIKG
GEVEELEKKXKELWKGPRRGEIEELHKKXHELIKG
GEVEELEKKXKELWKGPRRGEIEELHKKXhCELIKG
PinWW (F, E)
PinWW (X, E)
PinWW (F, Nva)
PinWW (F, Nva)
KLPPGWEKRMSRSSGRVYYFNHITEASQWERPSG
KLPPGWEKRMSRSSGRVYYXNHITEASQWERPSG
KLPPGWEKRMSRSSGRVYYFNHITNvaASQWERPSG
KLPPGWEKRMSRSSGRVYYXNHITNvaASQWERPSG
Peptides were purified by RP­HPLC on a Waters PrepLC using a Jupiter C18 300
Å (250 x 20.00 mm, 10 µm) column and a water/acetonitrile gradient eluent system.
Eluent A: 95% H2O, 5% CH3CN, 0.1% TFA; Eluent B: 5% H2O, 95% CH3CN, 0.1% TFA.
Crude peptides were dissolved in 100% Eluent A, filtered, and purified using focused
gradients. After RP­HPLC purification, all peptides were identified and assessed to be ≥
95% pure through LC­MS analyses (Tables 2­1 and 2­7). The desired fractions were
combined, lyophilized overnight, and redissolved in 2 mL of 8.0 M guanidinium chloride
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(GdmCl). Size exclusion chromatography was conducted using a HiLoad SuperdexTM 30
column eluted with a 0.22 µm­filtered phosphate buffer (20 mM NaPi, 150 mM NaCl, pH
= 7.3). Desired fractions were combined, and stock concentrations were determined by
measuring Trp absorbance (ε = 5690 M­1 cm­1 per Trp residue). Peptides were stored at 4
°C for future experiments.
IV. 	 Circular dichroism spectroscopy
For acquisition of spectra all peptides were dissolved in phosphate buffer (20 mM
NaPi, 150 mM NaCl, pH = 7.3). Spectra were collected on an Aviv Model 420
spectrometer (Aviv Biomedical, Inc., Lakewood, NJ) equipped with a temperature­
controlled cell holder and an autotitrator. Spectra were collected at both 25 °C and 2 °C
and several concentrations per peptide, scanning from 260 nm t0 200 nm at 1 nm
intervals. Integration time was 1 s and three scans were collected and averaged for all
peptide variants. A quartz cuvette with a 2 mm path length was used for all experiments.
To ensure folding reversibility, spectra were also taken at 25 °C after the completion of
thermal denaturation experiments.
V. 	 Thermal and chemical denaturation experiments – analysis of α2D
and PinWW variants
For the α2D series, all thermal denaturation experiments were monitored at 222
nm. Data were collected from 2 °C to 110 °C (at 2 °C intervals). For the PinWW series all
peptides were monitored at 226 nm and data were collected from 2 °C to 98 °C (at 2 °C
intervals). For each temperature point, the samples were allowed to equilibrate for 1 min
prior to data collection. Data were collected for 30 s and then averaged. Upon
completion samples were cooled down to 25 °C and spectra were acquired to confirm the
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highly reversible folding/unfolding behavior characteristic of α2D and PinWW (Figure
2­29).
Chemical denaturation experiments were performed on all PinWW variants to
assess their thermodynamic stabilities. For each experiment, two solutions were
prepared, one with 0.0 M GdmCl and the other with 8.0 M GdmCl (peptide
concentration was held constant at 10 µM). For each measurement, aliquots of 8.0 M
GdmCl were added so that the interval is 0.2 M increase. Peptides were monitored at 226
nm and data was collected for 30 s and averaged for each data point.
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­
 Figure 2­29. Representative CD data for PinWW and α2D variants. (a) CD spectra of α2D 
(F34F, F34F) at different concentrations before (square) and after (circle) thermal 
denaturation (T = 25 °C). Upon refolding there is little change to the global structure of the 
peptide. Reversibility is also independent of peptide concentration. (b) Thermal 
denaturation curves for (F34F, F34F) at different concentrations showcase the two­state 
folding behavior characteristic of α2D (λ = 222 nm). As predicted, a concentration 
dependence on the thermal stability is also observed. These curves are representative of the 
entire α2D series. (c) Thermal denaturation curves for PinWW F25ZpI N30E at 40 µM 
illustrates the two­state folding behavior characteristic of PinWW (λ = 226 nm). This curve is 
representative of the entire series; (d) Chemical denaturation curve for two PinWW mutants, 
also monitored at 226 nm. 
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For each α2D mutant thermal denaturation experiment were conducted at five
different concentrations and fit into a two­state model to general Tm values (Figure 2­
29). All α2D variants except (Cha, Cha) showed cooperative thermal melting behavior
(Figure 2­19).
VI.  Thermodynamic analysis of α2D variants – the van’t Hoff equation
Because α2D exists as a dimer when folded, its thermal stability should be
dependent upon its concentration. Therefore, the van’t Hoff equation can be utilized to
obtain the thermodynamic parameters ΔHf and ΔGf for each mutant:
Equation 1
�
Equation 2
�
Where Kf is the folding (or association) equilibrium constant, ΔHf is the enthalpy
of folding, and ΔGf is the free energy of folding. Because a significant change in the heat
capacity, C, of the α2D variants is unlikely, it is assumed that ΔHf is constant within the
temperature range of our experiments. With this assumption in place, Equation 2 can
be integrated to give:
Equation 3
�
Equation 4
�
Thus, a plot of lnKf against should be linear and have a slope equal to
(Figure 2­30). As mentioned previously, it is known that α2D
folding/unfolding follows the two­state model. According to this model, for a sample
with total monomer concentration Ctotal (mols L­1), at the Tm half the protein exists as
folded dimer while the other half exists as unfolded monomer. This can be expressed
mathematically as:
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Equation 5
�
The equilibrium constant Kf can then be calculated as:
Equation 6
�
Once the Kf values have been calculated for each peptide concentration, the ΔHf 
can be determined for each α2D variant using Equation 3 (Figure 2­30). Next,
Equation 1 can be integrated to give:
Equation 7
�
If T1 = Tm for a sample with a concentration of Ctotal then:
Equation 8
�
Thus, Equation 7 can be rearranged to give:
­
Equation 9
�
Here, the folding free energy, ΔGf2, can be calculated at temperature T2. We have
chosen to calculate folding free energy at T2 = 37 °C = 310 K.
Standard error estimation of ΔHf and ΔGf 
The standard error of each ΔHf value is obtained from the van’t Hoff plot as the
standard error of the linear fit.
For each ΔGf value, the standard error is calculated using the following equation:
Equation 10
�
Where T2 = 37 °C and T1 is a measured Tm value (the error associated with T1 is so
negligible that T1 is considered to be a constant). Therefore, Equation 10 can be
simplified to:
Equation 11
�
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The calculated errors for each ΔHf and ΔGf value can be found in Table 2­2,
Table 2­4, and Table 2­5 of the main text.
­
Figure 2­30. Van’t Hoff plots for selected α2D mutants, illustrating the linear
relationship. All other variants show similar behavior.
VII.  Computational calculations
All calculated physical parameters, including LogP, surface area, and dipole
moment, were generated with Spartan 2010 (Wavefunction, Inc.) using the PM3 semi­
empirical model (Table 2­3). For the 2­parameter fit (SLogPLogP + SDipoleDipole), SLogP is
the slope of the LogP vs. ΔGf linear fit while SDipole is the slope of the Dipole vs. ΔGf linear
fit (both for the (X, X) series).
100
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Calculated electrostatic potential density maps show red for negative potential 
and blue for positive potential (Figure 2­31). Calculations were conducted on toluene 
derivatives to best represent the phenylalanine sidechains. 
 
 
Figure 2­31. Calculated electrostatic potential maps (ESPs) for fluorinated Phe analogues. 
Areas of positive ESP (e– poor) are colored blue, while areas of negative ESP (e– rich) are 
colored red. All ESP maps were generated from the PM3 semi­empirical model in Spartan 
’10. 
 
VIII.  Disulfide crosslinking assay 
The α2D (X, X, hC) series of mutants were generated so that dimers, after 
reaching thermodynamic equilibrium in the reduced free thiol form, could be covalently 
crosslinked via disulfide bond formation when exposed to oxidative conditions. We 
selected the H30 position to be the mutation site because the C2 symmetry of the folded 
dimer places these residues from each monomer in close proximity to each other (x ≤ 5 
Å) (Figure 2­13). Furthermore, the H30hC mutation does not perturb the native 
structure or stability of the parent α2D variants (Figure 2­14). 
All peptides were dissolved in stock buffer (20 mM NaPi, 150 mM NaCl, pH = 
8.0). Peptide stock concentrations were calibrated prior to all experiments to ensure 
consistency, with all stock concentrations on the order of 1 mM. To ensure fully reduced 
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hCys residues, we incubated all samples with TCEP for 2 hrs. Next, the peptide samples
were diluted with oxidizing buffer (600 µM oxidized glutathione, 20 mM NaPi, 150 mM
NaCl, pH = 8.0) to a final concentration of 50 µM (for mixtures, each individual
component was diluted to a final concentration of 50 µM). The buffer’s pH of 8.0 was
chosen for these experiments in order to optimize the disulfide exchange kinetics. After
crosslinking was complete (2­4 hrs), samples were analyzed via LC­MS. Samples were
eluted at 0.2 mL min­1 on a C18 analytical column, using focused gradients of Eluent A
(95% H2O, 5% CH3CN, 0.1% TFA) and Eluent B (5% H2O, 95% CH3CN, 0.1% TFA).
Peptide populations were monitored by Trp absorbance at 280 nm, and cross­linked
dimers were identified using ESI­MS (Table 2­6).
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Chapter 3
�
Monitoring Transmembrane Helix Association via FlAsH­

tetracysteine Display: Towards the Design of Novel Inhibitors
�
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3.1  Introduction
�
The ability to further our understanding of the energetics of protein­protein
association in the cell membrane and subsequently modulate endogenous protein
association for therapeutic purposes necessitates simple yet reliable strategies for
monitoring protein­protein association in vitro. Though our studies with fluorinated
aromatics have demonstrated their potential as mediators of specific protein self­
assembly, we lack an ideal method of assessing their applicability in membrane systems.
Since the α­helix is the most commonly observed secondary structure in the
transmembrane domains of dimerizing proteins, our research has focused on these
transmembrane α­helices (TMHs). The current approaches to examining TMH
association propensity in vitro are summarized below.
3.1.1  Strategies for assessing transmembrane helix association
Currently available approaches for examining the association of TMHs include
genetic assays, analytical ultracentrifugation (AUC), Förster resonance energy transfer
(FRET), and disulfide exchange experiments. These methods will be briefly introduced
and discussed in light of the need for complementary techniques.
Genetic assays
Genetic screening systems, such as ToxR and TOXCAT, are capable of detecting
weak TMH interactions in the membrane of E. coli by monitoring gene expression levels.
In the ToxR system, Fritz and co­workers produced a chimeric protein, ToxR­TMH­
MalE, where the ToxR transcription activator is linked to the TMH of interest.1 The MalE
ensures the correct orientation of the TMHs. Upon TMH­induced association, the
oligomerized ToxR binds DNA and initiates transcription of the reporter gene (for ToxR,
this is β­galactosidase). The ToxR system has been utilized to examine both homo­
oligomerization and hetero­oligomerization.1, 2 A similar system, TOXCAT, was
developed by Engelman and co­workers and employs chloramphenicol acetyltransferase
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as the reporter.3 It has been utilized to assess changes in free energy due to TMH
oligomerization. While these genetic systems have been widely utilized, they do not allow
for the direct measurement of TMH association, and differences in expression levels
must be controlled.
Analytical ultracentrifugation
Analytical ultracentrifugation (AUC) is an effective method of assessing protein
molecular weight independent of its three­dimensional shape. In a properly designed
experiment oligomer formation can be monitored by the distribution of oligomers as a
function of protein concentration. Dissociation constants can be estimated from these
data. Experiments with membrane proteins, however, are complicated by the presence of
detergent, which is necessary to ensure solubility and the availability of native sequence
interaction motifs. Choosing the right detergent and solvent density are necessary for a
conducting the experiment, regardless of whether or not they correlate to the protein’s
natural state.4­7 An additional disadvantage to AUC is the inability to investigate TMH
association in vesicles due to their high molecular weight. Nevertheless, this method has
led to important observations about factors that contribute to TMH association in vitro.4­
FRET­based methods
In contrast to AUC, Förster resonance energy transfer (FRET) allows for TMH
association to be assessed in both detergent micelle and vesicle systems.8, 9 When a
monomeric TMH labeled with donor interacts with another acceptor­labeled TMH, the
FRET signal can be measured and correlated with association propensity. A FRET­based
strategy has even been utilized in a mammalian cell system.10 Despite its widespread use,
FRET measurements suffer from a few key limitations. At higher peptide­detergent
ratios, colocalization of the donor and acceptor fluorophores may introduce significant
baseline noise to the measurements and prevent the detection of small changes in
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association propensity. Moreover, the spatial resolution of FRET (>50 Å) may not allow
for subtle changes in dimer structure (i.e. orientation) to be detected. 
Disulfide cross­linking
DeGrado and co­workers have developed this method for use in both detergent
micelles and vesicles.11 The TMHs are labeled with Cys so that, upon dimerization, they
will be in close enough proximity to form a disulfide bond. While this strategy has not
seen as much widespread use, the high spatial resolution does allow for the detection of
antiparallel and parallel dimers.
While each of the methods described above have been used successfully to
examine TMH association in a number of different model systems, they all suffer from
fundamental limitations. An ideal in vitro technique would allow for the direct
measurement of TMH association in micelles and vesicles, be amenable to high
throughput applications, and possess an easily interpreted readout. Herein, we propose
that the biarsenical class of fluorophores is perfectly suited for monitoring TMH
association.
3.2  Biarsenical dyes as tools in chemical biology
Developed by Tsien and coworkers over a decade ago, biarsenical dyes, such as
the fluorescein analogue FlAsH, offer the ability to spatially and temporally monitor
proteins in vitro and in vivo.12, 13 These fluorescent probes are prepared with each arsenic
atom chelated by a small molecule dithiol, most commonly 1,2­ethanedithiol (EDT). It
was observed that in their EDT­protected forms, these dyes are essentially
nonfluorescent (i.e. FlAsH­EDT2). When placed in close proximity (< 10 Å) to a
tetracysteine (tC) motif, however, thiol­ligand exchange will occur (Figure 3­1a). The
newly­formed FlAsH­tC complex displays a markedly increased fluorescence emission
compared with FlAsH­EDT2. Although the mechanism behind the fluorescence increase
is not well understood, two hypotheses involve quenching by photoinduced electron
112
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transfer (PeT) (Figure 3­1b­c).14 The tC motif has been studied extensively, with the 
sequence CCPGCC binding FlAsH with the highest affinity.15 
 
 
Figure 3­1. Biarsenical dyes as tools in chemical biology. (a) Thiol­ligand exchange elicits 
strong fluorescence emission upon FlAsH­tC complex formation; (b) An orbital energy 
diagram demonstrating a possible mechanism for photoinduced electron transfer (PeT) 
quenching where the sulfur lone pair quenches the HOMO S0 of the fluorophore; (c) An 
orbital overlap diagram shows that EDT­bound FlAsH is quenched by the forced As orbital 
alignment with the chromophore. Image adapted from Reference 14. 
 
Over the last decade a variety of biarsenical dyes have been synthesized and 
utilized extensively to report on the folding, stability, and conformational changes of 
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numerous soluble proteins.13, 16­21 Notable applications will be discussed in greater detail
below.
3.2.1  Recent applications of biarsenical dyes
The ability of FlAsH to readily permeate the cell membrane has paved the way for
its use as a real­time fluorescent label in living cells. In one notable example, Gierasch
and co­workers have incorporated the CCPGCC motif into the surface­exposed loop of
mammalian protein CRABP I to directly monitor its stability and aggregation in bacteria
via FlAsH­tC binding (Figure 3­2).19 While in vivo experiments are often complicated
by the presence of high concentrations of endogenous protein, the low natural
abundance of cysteine ensures that the probability of FLAsH binding nonspecifically to
native bacterial protein or unmutated CRABP I is extremely low.
Figure 3­2. Monitoring CRABP I structure and stability in vivo using FlasH­tC display. (a)
A cartoon representation of CRABP I showing the location of the CCPGCC motif; (b) FlAsH
labeling of tC­labeled CRABP I is highly selective for the mutant over WT CRABP I.
The ability to introduce a FlAsH binding site into CRABP I without perturbing its
structure, and to selectively detect the mutant protein in the complex cellular
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environment represent key advantages of FlAsH­tC display. These results led to the
development of a FlAsH­tC reporter that is reconstituted from separate protein domains.
This approach has been named “bipartite­tetracysteine” display.
3.2.2  Bipartite­tetracysteine display in aqueous proteins
After the discovery that biarsenical dyes such as FlAsH bind to tC­containing
peptides, the optimal peptide sequence for high binding affinity was determined to be
CCPGCC, with the Pro­Gly residues playing an important role in preorganizing the tC
residues to favor the FlAsH­tC complex formation.12, 15 Schepartz and coworkers
hypothesized that this preorganization could also be achieved upon a conformational
change or association event that forces the four Cys residues into a conformation
favorable for FlAsH­tC complex formation. This approach, termed “bipartite­tC display”,
has been utilized to monitor soluble peptide dimerization (intermolecular tC display)
and changes in peptide conformation (intramolecular tC display) (Figure 3­3).
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Figure 3­3. Monitoring soluble protein association with partite­tetracysteine display
(images are adopted from Reference 14). (a) Carto0n demonstrating intramolecular tC
display in the aPP peptide using ReAsH; (b) A comparison of aPP with misfolded mutants
aPPF24P and aPPF24,Y31P shows preferential labeling of the WT structure; (c) Cartoon depicting
the detection of GCN4 dimers using bipartite FlasH­tC display; (d) FlasH only reports on
GCN4 dimers, as the L20P mutant does not associate. Images reproduced from reference 14.
In particular, the ability to quantitatively monitor the dimerization of GCN4
using the biarsenical probes FlAsH and ReAsH proves conceptually that this approach
should be adaptable to investigating the association of membrane­embedded proteins.
Our efforts toward the development and application of this assay will be described in the
following sections.
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3.3  FlAsH­tC display for quantifying TMH association in vitro
�
In addition to their previously discussed applications, most importantly the
bipartite­tC display approach, biarsenical dyes such as FlAsH­EDT2 offer untapped
potential as tools for monitoring protein­protein association in membrane
environments. We hypothesized that its small size and reported membrane permeability
makes it well suited to probing TMH association propensities. We have chosen to test
FlAsH­tC display using the model TMH peptides pL­X and MS1­X, both of which have
been well characterized by other methods.7, 11, 22­26 
3.3.1  pL­X and MS1­X – model peptides for validating FlAsH­tC display
We have chosen to test the ability of FlAsH­tC display to monitor the association
of two model TMH peptides, termed the pL­X and MS1­X series, which possess some
distinct features. The pL­X peptides were selected because their oligomerization states
had been previously characterized in both micelles (by AUC and SDS­PAGE) and the
plasma membrane of E. coli (using the genetic assay TOXCAT).22, 23 Consistent with
previous reports,22, 23 SDS­PAGE analysis shows that pL­N­dC exists predominantly (~
80%) as a dimer, presumably due to hydrogen bond formation between the Asn residues
of two helices. In contrast, pL­3F­dC shows little dimerization, which is expected
considering the lack of polar residues and a poorly defined interfacial region for van der
Waal’s packing (Figure 3­4).
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Figure 3­4. Tris­Tricine SDS­PAGE results for MS1­X and pL­X peptides. (a) MS1­X­dC
peptides: Lane 1 MS1­N­dC, Lane 2 MS1­L­dC, Lane 3 Ladder; (b) pL­X­dC peptides: Lane 1
pL­3F­dC, Lane 2 pL­N­dC.
The MS1­X TMH peptides have also been well characterized in model
membranes.7, 11, 24, 25 Designed by mutating the charged residues in the leucine zipper
GCN4 to hydrophobic sidechains, the MS1­X peptides offer a more well defined
interfacial region compared with the pL­X series. Nevertheless, the mode of association
is similar: MS1­N­dC is expected to readily dimerize due to its Asn residue, while MS1­L­
dC should remain monomeric (Figure 3­4). We hypothesized that, by tagging the N­
termini with dC motifs, dimerization of pL­N­dC and MS1­N­dC in the parallel
orientation will reconstitute a tC motif that will bind FlAsH through thiol­ligand
exchange. Thus, the observed emission should originate from the FlAsH­tC complex and
consequently represent the amount of dimerized protein.
3.3.2  Synthesis and characterization of the pL­X and MS1­X series
All MS1­X and pL­X variants were synthesized using Fmoc­based SPPS
conditions and the commercially available Rink­Amide MBHA resin. Fmoc­removal was
achieved by mixing with 20% v/v piperidine in N­N­dimethylformamide (DMF) twice for
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five minutes at room temperature. For each coupling step, five equivalents of the desired
amino acid were activated by HBTU and N­methylmorpholine (NMM) for two minutes
prior to coupling. The activated amino acid was then mixed with resin for thirty minutes
at room temperature to achieve amide bond formation. For difficult coupling steps,
amino acids were activated with HATU and mixed with resin for 1.5 hrs. A dicysteine
(dC) tag was joined to the N­terminus through a Gly­Gly linker (pL­X) or a βAla­βAla
linker (MS1­X). Lys residues were installed on all peptides to facilitate efficient synthesis
and purification.27 Resin cleavage and sidechain protecting group removal were achieved
simultaneously by mixing resin­bound peptide with a solution of 94% TFA, 2.5% H2O,
2.5% EDT, and 1% TIS at room temperature for 1.5­2 hrs. Ether precipitation followed by
centrifugation and vacuum drying yielded the crude product. All peptides were then
purified using prep scale RP­HPLC. After purification, all MS1­X and pL­X variants were
identified using MALDI­MS and assessed to be ≥ 95% pure through analytical LC (Table
3­1).
Table 3­1. MALDI­MS characterization of ctrl­X, MS1­X, and pL­X variants
Peptide MW Calculated (Da) MW Found (Da)
ctrl­tC
ctrl­dC
pL­3F­dC
pL­N­dC
pL­N­dCx2
MS1­L­dC
MS1­L­dA
MS1­N­dC
MS1­N­dA
1056.2
992.0
3093.1
2991.9
3312.3
3558.6
3494.5
3559.6
3495.5
1055.1
991.3
3091.2
2990.2
3311.0
3557.3
3493.1
3558.1
3494.0
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3.3.3  Enhanced FlAsH emission is a consequence of TMH association 
In designing our model peptides, we hypothesized that, upon parallel dimer 
formation, the dC motifs of each monomer would reconstitute a tC motif that is able to 
undergo thiol­ligand exchange with FlAsH­EDT2 (Scheme 3­1). Therefore, the 
measured fluorescence emission intensity should directly report on the amount of 
parallel dimer formed. However, in order for the measured emission to correlate directly 
with TMH association propensity, selective binding of FlAsH­EDT2 to the tC motif must 
be ensured. If the FlAsH­dC complex is allowed to form than the assay will not 
accurately report TMH association. More importantly, FlAsH should not be a facilitator 
of dimerization but only report on its occurrence. These legitimate concerns must be 
addressed before any experimental data can be interpreted. 
 
 
Scheme 3­1. FlAsH reports on dimer formation only in the presence of EDT. Cartoon 
demonstrates that FlAsH­tC complex formation is a biomolecular event. Formation of 
FlAsH­dC complexes is suppressed by excess EDT, which prevents FlAsH from driving TMH 
association since it can only bind to an already reconstituted tC motif. 
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Towards this end, we have conducted all experiments in the presence of excess 
EDT in order to suppress FlAsH binding to the dC motif. As previously discussed, Tsien 
and coworkers have demonstrated the reversibility of thiol­ligand exchange by the 
addition excess EDT in the presence of the FlAsH­tC complex to reconstitute FlAsH­
EDT2.12 Using the control peptides ctrl­tC and ctrl­dC, we have measured the emission 
intensity as a function of EDT concentration to identify the minimal amount of EDT 
needed to suppress FlAsH­ctrl­dC complex formation while not affecting FlAsH­ctrl­tC 
formation (Figure 3­5). The optimal EDT concentration was determined to be 0.250 
mM. The suppression of FlAsH­dC complex formation ensures that FlAsH cannot drive 
TMH association (Scheme 3­1). Moreover, the measured emission intensities should 
specifically report on FlAsH­tC complex formation. 
 
 
Figure 3­5. Influence of EDT on FlAsH­tC and FlAsH­dC complex formation. At a 
concentration of 0.250 mM EDT FlAsH­dC complex formation is effectively suppressed 
while FlAsH­tC complex formation is not significantly affected. 
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3.3.4  Quantifying TMH association in detergent micelles
In order to validate our assay, we chose to investigate the potential of FlAsH­tC
display as a reporter of TMH association in detergent micelles. Micelles are one of the
most commonly utilized model membrane systems due to their simple preparation, and
our results could be easily compared with those of other methods that are compatible
with micelles, such as SDS­PAGE and AUC. Dodecylphosphocholine (DPC), a mild,
zwitterionic detergent, was chosen to form the micelles.
In order to ensure proper insertion of all TMHs into our model membrane
system, peptides and detergents were premixed and dried to a thin film prior to
hydration with buffer (100 mM Tris, 200 mM NaCl, 3.5 mM TCEP, pH = 8.2). We first
examined the association propensities of pL­N­dC and pL­3F­dC in DPC micelles by
treating samples with excess FlAsH­EDT2 (2 eq.) for 2 hrs prior to the collection of
emission spectra. We hypothesized that the measured signal for pL­N­dC should be
higher than that of pL­3F­dC due to their preferences to exist as dimer and monomer,
respectively. As expected, much greater emission intensity was observed for pL­N­dC
than for pL­3F­dC (Figure 3­6a). Importantly, under the experimental conditions the
sample containing ctrl­dC yielded negligible emission, suggesting that the observed
fluorescence of pL­N­dC is due to the reconstitution of tC motifs via TMH association. A
small shift in emission intensity was observed for the ctrl­tC complex, which is most
likely due to a difference in the local environment upon complex formation (this
phenomena was observed for all subsequent experiments).
These initial results have demonstrated that our FlAsH­tC display assay readily
reports on TMH association through a simple fluorescence readout, and the association
propensities of pL­N­dC and pL­3F­dC are easily differentiated. A slightly increased
fluorescence emission was observed for pL­3F­dC in comparison to ctrl­dC, presumably
due to the elevated local concentration of FlAsH­EDT2 and pL­3F­dC sequestered in the
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DPC micelles. This colocalization effect could lead to the sequential binding of FlAsH to 
peptide monomers. Nevertheless, this dimer­independent emission of pL­3F­dC is 
minimal and can be subtracted to give the dimerization­induced FlAsH emission. 
Further characterization is necessary to utilize our assay for more than a qualitative 
examination of TMH association. 
 
 
Figure 3­6. The assessment of pL­X series association in DPC micelles via FlAsH­tC 
display. (a) Emission spectra for pL­N­dC and pL­3F­dC after 2 hr incubation with excess 
FlAsH­EDT2 (2 eq.). Samples were prepared using previously determined thiol­ligand 
competition conditions (0.250 mM EDT), with a DPC to peptide ratio of 500:1. Emission 
spectra were normalized to ctrl­tC emission intensity; (b) Plot showing the normalized 
fluorescence emission of pL­N­dC at 534 nm as a function of FlAsH­EDT2 concentration. A 
clear saturation profile is observed, which is indicative of complex formation. For 
normalization, the saturation intensity for ctrl­tC was considered to be 100% FlAsH­tC 
complex formation. 
 
In order to quantitatively investigate TMH dimer formation, it is essential that all 
reconstituted tC motifs are complexed with FlAsH. To determine the saturation 
concentrations of FlAsH­EDT2, we have performed a titration experiment against the 
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preformed pL­N­dC dimer, with ctrl­tC and ctrl­dC as references (Figure 3­6b). As
­
expected, both pL­N­dC and ctrl­dC display saturation behavior upon increasing
concentrations of FlAsH­EDT2, with apparent binding constants of 0.40 ± 0.11 µM and
0.51 ± 0.11 µM for pL­1N­dC and ctrl­N­dC, respectively. These data validate our peptide
design, as it appears our reconstituted tC motif binds FlAsH as well as the optimized ctrl­
tC peptide. Interestingly, at the saturation point the fluorescence intensity of pL­1N­dC is
only 30­35% of the ctrl­tC signal. Given the approximately 80% dimerization revealed by
SDS­PAGE for this peptide (Figure 3­4), the unexpectedly low emission intensity
suggests either the quantum yields of the complexes differ greatly, or the coexistence of
parallel and antiparallel dimers. A lack of preferential orientation upon dimerization is
not surprising for pL­N­dC, given its simple interfacial region that may not favor parallel
dimer over antiparallel. Due the close proximity (< 10 Å) necessary for thiol­ligand
exchange to occur, FlAsH­tC display should only be capable of reporting on the
formation of parallel dimer. This point has been investigated and will be discussed in
greater detail later.
In order to further characterize and validate our assay, we have quantified the
amount of crosslinked dimers present after FlAsH­EDT2 incubation via analytical HPLC.
As previously discussed, the formation of covalent complexes allows for isolation of the
FlAsH­tC species and represents a distinct advantage of FlAsH­tC display over other
methods of monitoring TMH association. In the absence of FlAsH­EDT2, pL­N­dC elutes
as a single peak corresponding to the monomeric peptide, with an EDT adduct as the
shoulder peak (Figure 3­7a). Upon addition of increasing amounts of FlAsH­EDT2 and
subsequent ligand exchange, the monomer peak decreases with a concomitant
appearance of the dimer peak. The dimers elute as a cluster of peaks due to the possible
regioisomers of the FlAsH­tC complex.28 
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Figure 3­7. Analytical HPLC characterization of pL­N­dC and pL­3F­dC in DPC micelles.
(a) HPLC traces for pL­N­dC (left) and pL­3F­dC (right) in the presence (1 eq.) and absence
of FlAsH­EDT2; (b) Plot comparing the pL­N­dC dimer fractions estimated by HPLC (black)
and the FlAsH­tC display assay (red) as a function of FlAsH­EDT2 concentration; (c) A very
good correlation exists between the florescence and HPLC results, further validating our
FlAsH­tC display assay.
Consistent with the fluorescence assay, the elution of pL­3F­dC is not
significantly affected by the presence of FlAsH­EDT2. We have estimated the fraction of
crosslinked pL­N­dC dimers by integrating the peak areas. As a function of FlAsH­EDT2 
concentration, the fraction of crosslinked dimers determined by HPLC agrees nicely with
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the normalized fluorescence emission intensities (Figure 3­7b­c). Importantly, these
­
data suggest that the fluorescent complexes formed by pL­N­dC and ctrl­tC with FlAsH
possess comparable quantum yields, and therefore FlAsH­tC display indeed serves as a
reliable readout for quantifying the amount of parallel pL­N­dC dimers present in DPC
micelles.
3.3.5  Quantifying TMH association in large unilamellar vesicles
In addition to examining the ability of our FlAsH­tC display to detect and
quantify TMH association in detergent micelles, we have also utilized it to investigate
TMH assembly in large unilamellar vesicles (LUVs), considered by many to be superior
to micelles as a membrane model. The ability of micelles to effectively mimic a biological
membrane is controversial.29 Nevertheless, the majority of previous reports assessing
TMH association have been carried out in micelles, largely because the commonly used
methods are not compatible with LUV systems.30 While we hypothesized that FlAsH­tC
display should be feasible with LUVs, it is imperative that FlAsH­EDT2 be able to readily
permeate the LUV membrane since the dC labels of the peptides will be evenly
distributed between the outer and inner leaflet of the LUVs. Although many reports
suggest that FlAsH­EDT2 readily permeates the membranes of living cells.12, 13, 15, 19 LUVs
lack active import mechanisms and have not been utilized with FlAsH. The kinetics of
LUV membrane permeation also remains unknown. These questions must be answered
before TMH association can be accurately quantified in LUVs.
In order to address these concerns, we developed an encapsulation experiment,
where 1­palmitoyl­2­oleoyl­sn­glycero­3­phosphocholine (POPC) LUVs were prepared
with and without ctrl­tC trapped on the inside of the vesicles (Figure 3­9a). The ctrl­tC
peptide has a net charge and should not leak out of the vesicles within the timescale of
our experiments. Moreover, ctrl­tC shows minimal binding to LUVs, as its Trp emission
spectrum is not shifted in the presence vs. the absence of POPC (Figure 3­8).
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 Figure 3­8. Normalized Trp emission spectra for ctrl­tC + FlAsH­EDT2 in the presence and 
absence of POPC LUVs. The max emission for both spectra occurs at 358 nm with little to no 
POPC­dependent shift in emission. 
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 Figure 3­9. Investigation of the ability of FlAsH­EDT2 to readily permeate POPC LUVs. (a) 
Cartoon illustrating the ctrl­tC encapsulation experiment. A signal increase upon FlAsH­
EDT2 addition should only be possible if the fluorophore gains access to encapsulated ctrl­tC; 
(b) Kinetic evaluation of FlAsH­EDT2 membrane permeability. FlAsH­EDT2 and triton X­
100 were added to the sample after 360 s and 3600 s, respectively; (c) Comparison of the 
kinetics of FlAsH­tC complex formation with encapsulated ctrl­tC and free ctrl­tC. The 
similar results suggest that FlAsH­EDT2 permeability is fast and should not influence 
complex formation on the timescale of our experiments. 
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The addition of FlAsH­EDT2 to the LUVs that contain ctrl­tC elicits an immediate
fluorescence emission increase, while the LUVs lacking encapsulated ctrl­tC show no
change in emission upon FlAsH­EDT2 addition. After a plateau in emission was attained,
triton X­100, which breaks up the LUVs, was added in order to obtain the emission
intensity representing 100% complex formation. No noticeable increase in emission
intensity was observed after triton X­100 addition, which suggests that all ctrl­tC
peptides were bound to membrane­permeable FlAsH­EDT2 prior to LUV lysis (Figure
3­9b). The binding kinetics of FlAsH­EDT2 to encapsulated ctrl­tC compares favorably
to the free peptide, suggesting that it diffuses quickly across the LUV membrane and
should therefore readily label tC motifs on both the inner and outer leaflets of the LUVs
(Figure 3­9c).
Once the effective LUV permeability of FlAsH­EDT2 had been established, we
examined the pL­X series in 100 nm liposomes made of 1,2­dilauroyl­sn­glycero­3­
phosphocholine (DLPC) in order to best match the length of the pL­X peptides. After
premixing and hydration with buffer (100 mM Tris, 200 mM NaCl, 3.5 mM TCEP, pH =
8.2), samples were allowed to equilibrate for at least 2 hrs. The association propensities
of pL­N­dC and pL­3F­dC in DLPC LUVs were then examined by treating samples with
0.250 mM EDT and excess FlAsH­EDT2 (2 eq.) for 2 hrs prior to the collection of
emission spectra (Figure 3­10a). As with the micelle system, pL­N­dC displays
significantly greater fluorescence intensity than pL­3F­dC, and ctrl­dC shows a negligible
signal.
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 Figure 3­10. Evaluation of TMH association in DLPC LUVs using FlAsH­tC display. (a) 
Emission spectra for pL­N­dC and pL­3F­dC after 2 hr incubation with excess FlAsH­EDT2 
(2 eq.). Samples were prepared using previously determined thiol­ligand competition 
conditions (0.250 mM EDT), with a lipid to peptide ratio of 500:1. Emission spectra were 
normalized to ctrl­tC emission intensity; (b) A comparison between pL­X series signal 
intensity in DPC micelles and DLPC LUVs. Unlike other currently used techniques, FlAsH­tC 
display is highly compatible with both model membrane systems. 
 
Furthermore, the emission intensity of pL­N­dC in DLPC LUVs is comparable to 
its signal in DPC micelles, an observation that lends additional support to the 
permeability of FlAsH­EDT2 across the LUV membranes (Figure 3­10b). The intensity 
of the FlAsH­pL­N­dC complex emission is also lower the that of ctrl­tC in the LUV 
model system, which supports our hypothesis that pL­N­dC dimers, showing no 
orientation preference, associate in both the parallel and antiparallel fashion. These data 
highlight a key advantage of FlAsH­tC display as a method of determining TMH 
association propensity: compatibility across multiple model membrane systems. 
We have also tested the general applicability of the FlAsH­tC display assay by 
examining the association propensity of the MS1­X peptides, which have been well 
characterized in model membranes and possess a drastically different interfacial region 
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than the pL­X series.7, 22, 24 As with the pL series, MS1­N­dC is expected to readily form 
dimers via sidechain hydrogen bonding, while MS1­L­dC should exist in the monomeric 
form.7, 24 In a similar fashion to the pL­X peptides, MS1­N­dC and MS1­L­dC were 
premixed with lipid and hydrated (POPC was chosen as the fatty acid chain length best 
matches the MS1­X series). Upon incubation with excess FlAsH­EDT2, the predicted 
emission spectra were observed for MS1­N­dC and MS1­L­dC: while MS1­N­dC 
displayed increased emission indicative of dimer formation, MS1­L­dC showed negligible 
fluorescence (Figure 3­11a).  
 
 
Figure 3­11. Evaluation of TMH association in POPC LUVs using FlAsH­tC display. (a) 
Emission spectra for MS1­N­dC and MS1­L­dC after 2 hr incubation with excess FlAsH­EDT2 
(2 eq.). Samples were prepared using previously determined thiol­ligand competition 
conditions (0.250 mM EDT), with a lipid to peptide ratio of 500:1. Emission spectra were 
normalized to ctrl­tC emission intensity; (b) Plot showing the normalized fluorescence 
emission of MS1­N­dC and MS1­L­dC at 534 nm as a function of FlAsH­EDT2 concentration. 
As with pL­N­dC, a clear saturation profile is observed, which is indicative of complex 
formation. For normalization, the saturation intensity for ctrl­tC was considered to be 100% 
FlAsH­tC complex formation. 
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Again, the maximum intensity of MS1­N­dC reaches only 40­45% of that of ctrl­
tC. Given that MS1­N­dC is known to dimerize completely, this observation suggests that
40% of the dimers adopt the parallel orientation and 60% orient in the antiparallel
fashion when oligomerized. These data are consistent with the findings of DeGrado and
coworkers, where the kinetics of thiol­disulfide exchange were used to estimate the
association and orientation of the MS1­X peptides.11 The point of dimer orientation will
be discussed in greater detail below.
3.3.6  FlAsH­tC display effectively distinguishes TMH dimer orientation
The ability of FlAsH­tC display to detect TMH dimerization in an orientation­
specific fashion represents an important advantage over traditional fluorescence
techniques such as FRET. This advantage originates presumably from the higher spatial
resolution of FlAsH­tC display: in order for thiol­ligand exchange to occur the molecules
must be within 10 Å. In contrast, FRET can occur efficiently within 50 Å. Since the lipid
bilayer typically spans 30 Å, it makes sense that FlAsH­tC display is only capable of
reporting parallel­oriented dimers. DeGrado and co­workers have already demonstrated
the utility of dimer orientation detection.11 
In order to prove our assay’s ability to differentiate parallel and antiparallel
dimer formation, we have synthesized a pL­X variant that displays dC motifs on both
termini. This peptide has been designated pL­N­dCx2 (Table 3­2). We hypothesized
that, after correcting for the number of dC labels per peptide, the emission intensity of
pL­N­dCx2 should be roughly double that of pL­N­dC, due to the ability to detect both
the antiparallel and parallel dimers of pL­N­dCx2 (Figure 3­12). As expected, pL­N­
dCx2 shows roughly double the fluorescence intensity when incubated with excess
FlAsH­EDT2.
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 Figure 3­12. FlAsH­tC display distinguishes parallel from antiparallel dimers. After 
correcting for the additional label per peptide, emission for pL­N­dC2x is close to double that 
of pL­N­dC, while pL­3F­dC and ctrl­dC show the expected lower emissions. The results 
agree well with SDS­PAGE analysis (Figure 3­4). 
 
The FlAsH­tC display of pL­N­dCx2 should report on the global dimerization, 
similar to SDS­PAGE. Indeed, the results correlate well with the amount dimer observed 
from gel electrophoresis. Thus both the total dimer formation and orientation preference 
can be determined with a single assay. The high spatial resolution of FlAsH­tC display  
3.3.7  Towards TMH inhibitors – preliminary competition experiments 
With an increased understanding of the important factors for TMH association, 
the design of inhibitors and eventually therapeutic agents is possible. We have begun 
preliminary tests to confirm our assay’s ability to monitor TMH inhibition using MS1­N­
dC and its unlabeled analogue MS1­N­dA, in which we have replaced the dC motif with 
an isosteric dA (Table 3­2). Because both peptides possess the same interfacial 
sequence, in particular the Asn residue, they should associate with each other when 
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mixed. We hypothesize that FlAsH­tC display will only report on the amount of MS1­N­

dC homodimer because the MS1­N­dC/A heterodimer and the MS1­N­dA homodimer do 
not possess the necessary tC m0tif.  
 
 
Figure 3­13. Examining inhibition of MS1­N­dC dimerization via FlAsH­tC display. (a) 
Emission spectra showing a decrease in intensity as the amount of pL­N­dA increases; (b) 
Emission intensity decreases as a function of pL­N­dA. 
 
Our initial experiments demonstrate the ability of pL­N­dA to compete with pL­
N­dC dimerization (Figure 3­13). While encouraging, these results must be further 
investigated by titrating with MS1­L­dA as a negative control. Also, we have begun 
efforts to facilitate specific TMH self­assembly using fluorinated aromatic amino acids. 
These experiments are currently in progress. 
3.3.8  Summary of FlAsH­tetracysteine display 
We have described the successful development and characterization of a FlAsH­
tC display assay for quantifying the association propensities and orientation preferences 
of two model TMHs, pL­X and MS1­X.28 Unlike many fluorescent probes, FlAsH­EDT2 is 
easily prepared in gram quantities from fluorescein, a cheap and widely available 
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chromophore. The assay is compatible with two of the most widely utilized in vitro model
membrane systems, detergent micelles large unilamellar vesicles (LUVs), and the
fluorescent readout allows for efficient and accurate data analysis. Although this
approach has been applied to monitor the association of soluble α­helical peptides14, to
the best of our knowledge our assay is the first example of applying this “split­tC”
strategy to quantify membrane­embedded protein dimerization. The assay’s ability to
directly report on dimerization, to distinguish parallel and antiparallel dimers, and to
monitor association inhibition represent critical advantages for its use in studying
membrane protein association.
3.4  Conclusion
In summary, we have adopted the bipartite­tC display strategy to the
investigating of TMH association. An effective method for monitoring and quantifying
membrane protein association will lead to a better understanding of protein­protein
interactions in the membrane. Due to their favorable electronic properties, we
hypothesize that fluorinated aromatic amino acids are an ideal set of chemical tools for
manipulating the association of endogenous transmembrane domains. Future plans
towards this goal are briefly discussed in the final chapter.
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Experimental Procedures
�
I.  General methods
All chemicals were obtained from Thermo Fisher Scientific (Waltham, MA) or
Sigma­Aldrich (St. Louis, MO) unless otherwise noted. Rink­Amide­MBHA resin was
purchased from Novabiochem (San Diego, CA). All Fmoc­protected natural α­amino
acids, HBTU, HATU, and piperidine were purchased from Advanced Chemtech
(Louisville, KY). N­methylmorpholine (NMM) was purchased from TCI AMERICA
(Portland, OR). Fmoc­N­β­alanine (Fmoc­B) was purchased from Chem­Impex
International, Inc. (Wood Dale, IL). Dodecylphosphocholine (DPC) was purchased from
Affymetrix, Inc. (Santa Clara, CA). The phospholipids 1­palmitoyl­2­oleoyl­sn­glycero­3­
phosphocholine (POPC) and 1,2­dilauroyl­sn­glycero­3­phosphocholine (DLPC) were
purchased from CordenPharma International (Plankstadt, Germany). The biarsenical
dye 4’,5’­bis(1,3,2­dithioarsolan­2­yl)fluorescein­1,2­ethanedithiol (FlAsH­EDT2) was
easily prepared from fluorescein in gram quantities according to previously reported
protocol.31 Peptide synthesis was carried out on a Tribute® peptide synthesizer (Protein
Technologies, Tucson, AZ). All crude peptides were purified by RP­HPLC using a Jupiter
C4 300 Å (250 x 15.00 mm, 10 µm) semi­prep column (Phenomenex, Inc., Torrance, CA)
on a Waters PrepLC system (Waters Corporation, Milford, MA). All MALDI­MS data
were generated by the Boston College Mass Spectrometry Facility (NSF grant no. DBI­
0619576). Protein concentration was determined spectrophotometrically by measuring
Trp absorbance at 280 nm (ε = 5690 M­1 cm­1 per Trp residue) with either a Lambda 25
UV­Vis spectrometer (PerkinElmer, Waltham, MA) or a Nanodrop 2000c
spectrophotometer (Thermo Fisher Scientific). Large unilamellar vesicles (LUVs) were
prepared using the Lipofast Mini Extrusion system (Avanti Polar Lipids, Alabaster, AL)
followed by size exclusion chromatography using a HiLoad SuperdexTM 30 column on the
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ÄKTA FPLC system (GE Healthcare, Piscataway, NJ). The uniform size distribution of all 
LUVs was verified using a DynaPro NanoStar dynamic light scatterer (Wyatt Technology 
Corporation, Santa Barbara, CA). Phospholipid concentration was determined using the 
reported Stewart Assay.32 All fluorescence spectra were collected, using 96­wellplates or 
a cuvette, on either a SpectraMax5 fluorescence plate reader (Molecular Devices, 
Sunnyvale, CA) or a Fluorolog spectrometer (Horiba Jobin Yvon FL3­22). All SDS­PAGE 
gels were stained with the commercially available Silver Staining Kit (Sigma, Aldrich). 
 
II.  Synthesis of FlAsH­EDT2 
The biarsenical probe FlAsH­EDT2 was prepared in gram quantities from the 
commercially available fluorescein. After synthesis the stolid is highly stable when stored 
in the dark at –20 °C (Scheme 3­2). 
 
 
Scheme 3­2. Preparation of FlAsH­EDT2 3 from fluorescein 1. Conditions: (a) HgO, TFA, 
22 °C, 5 hrs; (b) AsCl3, Pd(OAc)2, DIEA, NMP, 60°C, 3hrs; (c) EDT, aqueous acetone, 30 
mins. Synthesis was conducted by Dr. Fang Wang according to previously reported 
protocol.31 
 
III.  Peptide synthesis, purification, and characterization 
All peptides were synthesized via automated solid phase peptide synthesis 
(SPPS) on a Tribute® peptide synthesizer (Protein Technologies, Tucson, AZ) using 
standard Fmoc/tBu chemistry (Table 3­2). Syntheses were performed using 0.05­0.1 
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mmol Rink­Amide MBHA resin as the solid support (depending on the scale). All MS1­X
­
and pL­X peptides were synthesized with an N­terminal amine and a C­terminal amide,
while the ctrl­X peptides were prepared with an acetylated N­terminus. Acetylation was
achieved by treating the resin­bound peptide twice with 10% v/v acetic anhydride in
DMF for 30 mins at room temperature. Removal of the Fmoc protecting group was
accomplished by treating resin­bound peptide with a solution of 20% v/v piperidine in
DMF twice for 5 mins at room temperature under N2 protection. For standard coupling
steps, 5 eq. of Fmoc­protected amino acid were mixed with 5 eq. of HBTU and
subsequently dissolved in a solution of 0.4 M N­methylmorpholine (NMM) in DMF.
After 2 mins the activated amino acid solution was delivered to the resin under N2
protection and mixed for 30 mins at room temperature. For difficult coupling steps
activation was mediated by HATU with otherwise identical conditions to standard
coupling. If deemed necessary, the amino acid coupling efficiency was monitored by the
Ninhydrin test. After difficult coupling steps, unreacted free amines were capped by
treating resin with 10% v/v acetic anhydride in DMF twice for 30 mins at room
temperature under N2 protection. Upon completion of SPPS, peptide removal from resin
and sidechain deprotection were simultaneously accomplished by treating resin­bound
peptide with a freshly prepared solution of 94% TFA, 2.5% H2o, 2.5% EDT, 1% TIS for
1.5­2 hrs at room temperature. Ether precipitation followed by centrifugation and drying
under vacuum yielded the crude products as off­white solids.
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Table 3­2. Primary sequences of ctrl­X, MS1­X, and pL­X variants
­
Peptide Primary Sequence
ctr­tC
ctr­dC
MS1­L­dC
MS1­L­dA
MS1­N­dC
MS1­N­dA
pL­3F­dC
pL­N­dC
pL­N­dCx2
WDCCPGCCK
WDAAPGCCK
CCBBQLWIALLLLIAVLLILLIALARLKKKKK
AABBQLWIALLLLIAVLLILLIALARLKKKKK
CCBBQLWIALLLLIAVNLILLIALARLKKKKK
AABBQLWIALLLLIAVNLILLIALARLKKKKK
WKKKCCGGLLLFLLLFLLFLLLLKKK
WKKKCCGGLLLNLLLLLLLLLLLKKK
WKKKCCGGLLLNLLLLLLLLLLLGGCCKKK
Peptides were purified by RP­HPLC on a Waters PrepLC using a Jupiter C4 300
Å (250 x 15.00 mm, 10 µm) semi­prep column and a water/acetonitrile gradient eluent
system. Eluent A: 95% v/v H2O, 5% v/v CH3CN, 0.1% v/v TFA; Eluent B: 5% v/v H2O,
95% v/v CH3CN, 0.1% v/v TFA. Crude peptides were dissolved in 70% Eluent A 30%
Eluent B, filtered, and purified using a gradient of 30­70% Eluent B over 20 mins. After
RP­HPLC purification, all peptides were identified using MALDI­MS and assessed to be
≥ 95% pure through analytical HPLC (Table 3­1). Peptides were lyophilized and stored
at 2 °C.
IV.  Suppressing nonspecific FlAsH­peptide complex formation with EDT
To determine the minimal EDT concentration for suppressing FlAsH­dC complex
formation while still allowing for complete FlAsH­tC complex formation, 3 µM ctrl­tC 
and 6 µM ctrl­dC were dissolved in buffer (100 mM Tris, 200 mM NaCl, 3.5 mM TCEP,
pH = 8.2) and incubated with varying concentrations of 1.2­ethanedithiol (EDT). An
excess of FlAsH­EDT2 (3 eq.) was added to each sample before they were loaded onto a
96­wellplate as triplicates. The plate was sealed with clear packing tape prior to
fluorescence emission measurements. Samples were excited at 488 nm, and emission
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was monitored at 534 nm. The average emission intensities (standard deviation was less
­
than 5% of the total mean signal intensities) were plotted as a function of EDT
concentration (Figure 3­5). The optimal EDT concentration for all subsequent
experiments was determined to be 0.250 mM.
V.  Assessing FlAsH­tC complex formation in detergent micelles
For each peptide, stock solutions of 50 µM in MeOH were prepared by
monitoring Trp absorbance at 280 nm (ε = 5690 M­1 cm­1 per Trp residue). To ensure full
reduction of the cysteines prior to the addition of detergent, TCEP was added to each
stock to a final concentration of 1 mM. Samples were incubated at room temperature for
2 hrs. Next, DPC was dissolved in chloroform and added to the peptide samples. Solvent
was evaporated under reduced pressure and samples were dried under high vacuum. All
samples were then hydrated with buffer (100 mM Tris, 200 mM NaCl, 3.5 mM TCEP, pH
= 8.2). After hydration, samples were allowed to equilibrate at room temperature for a
minimum of 2 hrs. For all samples, the final ratio of detergent to peptide was 500:1.
Once peptides were premixed with detergent and hydrated, EDT was added to
each sample to a final concentration of 0.250 mM. Stocks of FlASH­EDT2 were prepared
in dry DMSO in the range of 1 mM concentration (depending on the dilution factor; final
concentrations of FlAsH­EDT2 are in the µM range, so the final concentration of DMSO
in each sample is 0.1% v/v). Next, samples were loaded onto 96­wellplates in 0.150 mL
aliquots as triplicates. Plates were sealed with clear packing tape after sample addition to
prevent air oxidation during measurements. Although ligand exchange is almost always
completed within 1 hr, samples were incubated with FlAsH­EDT2 for up to 2 hrs at room
temperature to ensure complete ligand exchange for all samples regardless of FlAsH­
EDT2 concentration. Fluorescence spectra were monitored and collected using a
SpectraMax5 plate reader. Sampled were excited at 488 nm, and FlAsH­tC complex
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emission was monitored from 520 nm to 560 nm (data collected at 2 nm intervals). All
­
FlAsH­EDT2 titration measurements were conducted using this standard protocol unless
otherwise noted.
In order to verify FlAsH­tC complex formation, samples were examined using
analytical HPLC. Peptide samples of 0.120 mL were mixed with EDT and FlAsH­EDT2 as
described above. Analytical HPLC experiments were conducted on a Waters e2695
analytical LC system using a Jupiter C4 300 Å (150 x 2.00 mm, 5 µm) column, and
peptides were monitored by measuring Trp absorbance at 280 nm. Peak areas were
integrated using the Empower Pro software suite.
VI.  Assessing FlAsH­tC complex formation in LUVs
For each peptide, stock solutions of 50 µM in MeOH were prepared by
monitoring Trp absorbance at 280 nm (ε = 5690 M­1 cm­1 per Trp residue). To ensure full
reduction of the cysteines prior to the addition of detergent, TCEP was added to each
stock to a final concentration of 1 mM. Samples were incubated at room temperature for
2 hrs. Next, POPC (MS1­X series) or DLPC (pL­X series) was dissolved in chloroform
and added to the peptide samples. Solvent was evaporated under reduced pressure and
samples were dried under high vacuum. All samples were then hydrated with buffer (100
mM Tris, 200 mM NaCl, 3.5 mM TCEP, pH = 8.2). After hydration, samples were
allowed to equilibrate at room temperature for a minimum of 2 hrs. For all samples, the
final ratio of detergent to peptide was 500:1. After brief sonication, samples were
extruded through a 100 nm membrane 20 times using the Lipofast Mini Extrusion
system to form 100 nm LUVs. Following extrusion, the uniform size distribution of all
LUVs was verified using a DynaPro NanoStar dynamic light scatterer. Final phospholipid
concentrations were determined using the reported Stewart Assay.32 
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Once peptide­LUV samples were prepared, EDT was added to each sample to a
final concentration of 0.250 mM. Stocks of FlASH­EDT2 were prepared in dry DMSO in
the 1 mM concentration range (depending on the dilution factor; final concentrations of
FlAsH­EDT2 are in the µM range, so the final concentration of DMSO in each sample is
0.1% v/v). Next, samples were loaded onto 96­wellplates in 0.150 mL aliquots as
triplicates. Plates were sealed with clear packing tape after sample addition to prevent air
oxidation during measurements. Although ligand exchange is almost always completed
within 1 hr, samples were incubated with FlAsH­EDT2 for up to 2 hrs at room
temperature to ensure complete ligand exchange for all samples regardless of FlAsH­
EDT2 concentration. Fluorescence spectra were monitored and collected using a
SpectraMax5 plate reader. Sampled were excited at 488 nm, and FlAsH­tC complex
emission was monitored from 520 nm to 560 nm (data collected at 2 nm intervals). All
FlAsH­EDT2 titration measurements were conducted using this standard protocol unless
otherwise noted.
Compared with the micelllar system, the dimerizing peptides in LUVs give
comparable FlAsH­tC complex emission intensities (Figure 3­14). These data support
our assertion that FlAsH­EDT2 is highly membrane­permeable. This point is addressed
in greater detail in the next section.
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 Figure 3­14. Comparison of FlAsH­tC emission spectra for MS1­N­dC in DPC micelles with 
emission in POPC LUVs. Spectra were collected after incubation with 2 eq. FlAsH­EDT2 for 2 
hrs. The spectra for ctrl­tC are also shown as a reference that further validates the membrane 
permeability of FlAsH­EDT2. 
 
VII.  Confirming the LUV membrane permeability of FlAsH­EDT2 
To validate our claim that FlAsH­EDT2 readily permeates LUVs, we encapsulated 
ctrl­tC in POPC LUVs. Peptide and POPC were premixed and hydrated, according to the 
previously described protocol, to final concentrations of 20 µM ctrl­tC and 20 mM 
POPC. Extrusion through a 100 nm membrane yielded the desired LUVs. All ctrl­tC 
outside of the formed LUVs was removed via size exclusion chromatography. Final 
phospholipid concentrations were determined using the reported Stewart Assay.32 An 
identical sample without ctrl­tC was prepared to act as the negative control. 
A kinetics experiment was employed to examine the membrane­permeability of 
FlAsH­EDT2. Samples (1.8 mL) were loaded into a 10 mm quartz cuvette containing a 
stir bar, and fluorescence emission was monitored using a Fluorolog spectrometer. 
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Samples were excited at 488 nm and emission was monitored at 534 nm as a function of
­
time. Next, FlAsH­EDT2 was added to a final concentration of 3 µM, and emission
intensity was monitored until a clear plateau was evident (approximately 1 hr). To obtain
the signal for 100% FlAsH­tC complex formation, LUVs were broken by the addition of
triton X­100 (to a final concentration of 0.2% v/v). The emission intensity was
monitored for an additional 30 mins. Samples without ctrl­tC were subtracted to give the
emission of the FlAsH­tC complex.
We have also conducted a Trp fluorescence assay to demonstrate that the ctrl­tC
peptide does not associate with the POPC LUVs, as this behavior could affect the
membrane permeability measurement (Figure 3­8). Samples of ctrl­tC, with and
without POPC LUVs, were loaded into a 10 mm quartz cuvette. Samples were excited at
275 nm, and emission was monitored from 320 nm to 400 nm. Samples without ctrl­tC
were used as controls and subtracted to give the emission spectra of the FlAsH­tC 
complex in the presence and absence of POPC LUVs.
VIII.  Competition assay with the MS1­X series
For each peptide, stock solutions of 50 µM in MeOH were prepared by
monitoring Trp absorbance at 280 nm (ε = 5690 M­1 cm­1 per Trp residue). To ensure full
reduction of the cysteines prior to the addition of detergent, TCEP was added to each
stock to a final concentration of 1 mM. Samples were incubated at room temperature for
2 hrs. All MS1­N­dC and MS1­N­dA samples were premixed to the desired molar ratios.
For these experiments, a control sample was set up for every mixture where [MS1­N­dA]
= [MS1­N­dC] + [MS1­N­dA]. Next, DPC was dissolved in chloroform and added to the
peptide samples. Solvent was evaporated under reduced pressure and samples were
dried under high vacuum. All samples were then hydrated with buffer (100 mM Tris, 200
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mM NaCl, 3.5 mM TCEP, pH = 8.2). After hydration, samples were allowed to
equilibrate at room temperature for a minimum of 2 hrs.
Once peptides were premixed with detergent and hydrated, EDT was added to
each sample to a final concentration of 0.250 mM. Stocks of FlASH­EDT2 were prepared
in dry DMSO in the range of 1 mM concentration (depending on the dilution factor; final
concentrations of FlAsH­EDT2 are in the µM range, so the final concentration of DMSO
in each sample is 0.1% v/v). Next, samples were loaded into a quartz cuvette for
measurements. Samples were incubated with FlAsH­EDT2 for 1 hr at room temperature
to ensure complete ligand exchange for all samples regardless of FlAsH­EDT2 
concentration. Fluorescence spectra were monitored and collected using a SpectraMax5
plate reader. Sampled were excited at 488 nm, and FlAsH­tC complex emission was
monitored from 520 nm to 560 nm (data collected at 2 nm intervals).
IX.  Tris­Tricine SDS­PAGE analysis of MS1­X, pL­X peptides
Peptides were premixed with DPC and hydrated with buffer (100 mM Tris, 200
mM NaCl, 3.5 mM TCEP, pH = 8.2) according to previously described protocol. After
being allowed to equilibrate for at least 2 hrs, 32 µL samples were mixed with 16 µL of
loading dye (containing 20% v/v glycerol) prior to gel loading. Tris­Tricine precast 10­
20% gradient gels (BioRad Laboratories, Hercules, CA) were used for these experiments.
For apparent mobility­molecular weight correlation, a Color Marker Ultra Low Range
(Molecular Weight 1,060­26,600 Da) ladder (Sigma Aldrich) was loaded with onto each
gel. Gels were run at 4 °C for 2 hrs at 80 Amps with the following buffer: 0.1% wt/v SDS,
100 mM Tris, 200 mM Tricine, pH = 8.2. Gels were stained using the protocol described
in the Silver Staining Kit (Sigma Aldrich) (Figure 3­4).
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4.1  Targeting the TM domain of ErbB2 
The ultimate goal of investigating and understanding the properties of 
fluorinated aromatic amino acids is to apply them to the modulation of membrane 
protein oligomerization for therapeutic purposes.1­5, 5­9 In addition, the validation of 
FlAsH­tC display as an efficient technique for evaluating the association of TMHs allows 
us to begin assessing the ability of fluorinated aromatics to facilitate association in a 
membrane environment. The result is convergence on a target TMH of interest for proof 
of concept studies (Figure 4­1). We have selected the TMH domain of the RTK ErbB2 as 
our target, as it offers a number of advantages, most importantly a reported oligomeric 
structure that localizes a native Phe in the interfacial region.10 
 
 
Figure 4­1.Future direction: targeting endogenous TMHs with Fluorinated aromatics. 
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For this model system, we have hypothesized that an established edge­face
interaction between a tetrafluorinated Phe derivative (Zp shown) and a native Phe could
be energetically significant enough in the hydrophobic lipid bilayer to drive TMH
association. We have begun investigating the potential of aromatic interactions in
facilitating TMH association using the pL­X series, but these experiments were
unsuccessful and saw no dimer formation when peptides containing Phe and Z were
mixed (data not shown). An alternative approach involves utilizing fluorinated aromatics
to induce dimer orientation preference in an already dimerizing model peptide. Efforts
towards these goals are currently underway.
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